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Two members of the phosphoenolpyruvate mutase (PEPM) / isocitrate lyas
(ICL) superfamily were investigated to study their structure-f nction relationships and to 
identify sequence signatures that define a particular function. The first nzyme (PA4872) 
was a protein of unknown function from Pseudomonas aeruginosa. The second enzyme 
from Aspergillus niger (An07g08390) was thought to be an oxaloacetate acetyl hydrolase 
(OAH) because of its high sequence identity (~60%) to an enzyme with confirmed OAH 
activity. 
The X-ray crystal structure determination of PA4872 revealed unique features that 
guided the design of biochemical experiments, which ultimately led to the discovery that 
the enzyme is an oxaloacetate decarboxylase (OAD). Two structures of An07g08390, one 
with bound Mg2+ and the second with bound Mn2+ and the inhibitor 3,3-
difluorooxaloacetate, were determined. The functional studies demonstrated th  although 
  
the enzyme has OAH activity, it has a far better activity as a 2R,3S-dimethylmalate lyase 
(DMML). The active site structure of DMML indicated a proline residue (Pro240) as a 
marker of DMML function along with confirming the conserved locations f previously 
established signature residues for lyase activity. 
 OAD is the founding member of a family within the PEPM / ICL superfamily and 
thus defines the function of the remaining family members. However, th  biological 
context in which OAD functions remains unknown. DMML is known to function in the 
nicotinate catabolism pathway but not all the members of the pathway are present in A. 
niger. Transcriptome analysis suggests that the DMML encoding gene is under carbon 
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Chapter 1   Introduction 
 Molecular recognition of substrates by enzymes depends on the active site 
structure. The size and shape of the molecule that is accommodated in the active site is 
dictated by the residue distribution lining the active site. In order to understand the 
function and mechanism of an enzyme, a deeper knowledge of the atomic details of he 
structure is important. 
 My research focus has been the structure/function study of the 
phosphoenolpyruvate mutase (PEPM) / isocitrate lyase (ICL) superfamily of proteins.  
This is an unusual superfamily because its members share high sequenc  identity and the 
same overall fold, yet they function in diverse biological contexts and carry out a wide 
range of biochemical functions. Structural studies of several PEPM/ICL superfamily 
members using X-Ray crystallography have already been carried out in our laboratory to 
gain insight into the structural determinants that define diversification of function and to 
identify signature residues that help in the assignment of function of new sequences that 
belong to the PEPM/ICL superfamily. My research concentrated on two of the 
superfamily members, oxaloacetate decarboxylase (OAD) and 2, 3–dimethylmalate lyase 
(DMML).  
 In the studies of OAD and DMML the structural work including crystallization, 
X-ray diffraction data collection, structure determination, refinement, validation and 
structure analysis were carried out by myself in the laboratory of Dr. Osnat Herzberg at 
the Center for Advanced Research in Biotechnology and the biochemical and 
enzymology work were carried out in the laboratory of Dr. Debra Dunaway-Mariano at 
the University of New Mexico. The molecular architecture revealed by the three 
 2
dimensional structures helped develop hypothesis about the catalytic mechanism and 
substrate specificity which were then tested by site directed mutagenesis. An introduction 
to the PEPM/ICL superfamily is covered in this chapter. An overview of the 
methodology (X-Ray-Crystallography) is described briefly in the following chapter. 
1.1 The PEPM/ICL superfamily 
 
 The PEPM/ICL superfamily consists of enzymes that catalyze a C-C bond 
formation or cleavage and those that catalyze a P-C bond formation or cleavage reactions 
in α-oxycarboxylate substrates (Fig. 1.1). The known C-C bond catalyzing enzymes are 
isocitrate lyase (ICL) (Vanni, Giachetti et al. 1990), 2- methylisocitrate lyase (MICL) 
(Horswill and Escalante-Semerena 1999), petal death protein (PDP) (Lu, Feng et al. 
2005; Teplyakov, Liu et al. 2005), DMML, OAD, oxaloacetate acetyl hydrolase (OAH) 
(Han, Joosten et al. 2007) and ketopantoate hydroxymethyl transferase (PanB) (Jones, 
Brook et al. 1993). Enzymes acting on a P-C bond are PEPM (Seidel, Fre man et al. 
1988), carboxy phosphoenolpyruvate mutase (CPEPM) (Pollack, Freeman et al. 1992), 
and phosphonopyruvate hydrolase (PPHA) (Kulakova, Wisdom et al. 2003). The 
chemical reactions proceed via an oxyanion intermediate and/or transition state with the 




). The lyase branch of the superfamily 
(ICL, MICL, OAH, PDP) catalyzes the cleavage of the C(2)-C(3) bond of various α-
hydroxyacid substrates to form a α-oxyanioncarboxylate intermediate/transition state and 
an aci-carboxylate anion intermediate/transition state (Liu, Lu et al. 2005). In contrast, 
the known enzymes of the P-C bond forming/cleaving branch (PEPM, CPEPM and 





Figure 1.1: Reactions catalysed by the PEPM/ICL superfamily. Conserved pyruvyl/glyoxyl 




intermediate/transition state (Huang, Li et al. 1999; Chen, Han et al. 2006). The 
stabilization of these intermediates form the core chemistry of these enzymes (Lu, Feng 
et al. 2005). Our work on OAD revealed that this enzyme also involves an enolate 
intermediate (Narayanan, Niu et al. 2008). 
In addition to the wide range of biochemical functions, the PEPM / ICL
superfamily enzymes function in diverse range of biological processes spanning primary 
and specialized secondary metabolisms. For example, the C-C bond cleaving activity of 
the highly specific enzyme, ICL, is utilized in the glyoxylate pathway (Vanni, Giachetti 
et al. 1990) and that of MICL is utilized in the methylcitrate cycle (McFadden, Rose et al. 
1972; Brock, Darley et al. 2001). In contrast, PDP exhibits broad substrate specificity and 
is associated with programmed petal death, where it may be used to accumulate nutrients 
for seed development (Lu, Feng et al. 2005; Teplyakov, Liu et al. 2005). The enzym s 
that act on P-C bonds, PEPM and carboxyPEPM, function in phosphonate biosynthesi . 
Whereas, PPHA functions in phosphonate degradation. 
Members of the PEPM/ICL superfamily usually oligomerize into tetramers 
consisting of dimer of dimers (Fig 1.2 ) except in PanB where the dim rs form decamers 
(pentamers of dimers) (Chaudhuri, Sawaya et al. 2003; Schmitzberger, Smith et al. 2003). 
A recently published paper on a new member of unknown function from the superfamily, 
DFA0005, reported that in this case the dimer is the physiologically relevant assembly 
(Liao, Chin et al. 2008). The basic dimeric building unit associate similarly regardless of 
the overall oligomeric state. The overall fold characteristic to the PEPM/ICL superfamily 
is an α/β-barrel fold where the eighth  α-helix of one barrel extends out to pack against 
the barrel of the partner protomer (except for one PanB structure from E.coli 
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(Schmitzberger, Smith et al. 2003)). After swapping, the eighth α-helix ensuing chain 
forms a helix- loop- helix C-terminus that covers the active ste of the partner molecule. 
The structure of OAD that I determined provides a new variation in which the C- erminus 
switch the direction back to its own active site. The active site i  located at the C-terminal 
edge of the barrel’s β sheets. The cavity is gated by a capping loop that undergoes 
conformational changes, yielding an open or closed active site. The open conformation 
exposes the active site to bulk solvent and enables substrate binding and product release. 
Upon substrate binding, the loop closes to sequester the active site from the solvent. The 
gating loop closure brings key catalytic residues in close proximity to the substrate and 
protects the intermediate/transition states from solvent.  
 
Figure 1.2: (A) Tetramer structure of PPHA. The dimer association showing helix swapping is 
seen between the monomers colored green and purple (B) Monomer of PPHA (adapted from 
(Chen, Han et al. 2006)) showing Mg2+ as magenta sphere and phosphonopyruvate (stick 
representation) in the active site. 
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 The catalytic scaffold provides a binding pocket for the α-oxycarboxylate 
substrate that includes residues engaged in hydrogen bond formation with the C(1) 
carboxylate, and residues that bind the Mg2+ cofactor directly or via water molecules 




 is crucial for effective catalysis in all PEPM / 
ICL superfamily enzymes and its coordination geometry and mode of engaging both 
protein residues and substrate are conserved.  
 
Figure 1.3: Active site of DMML 
The sequence alignment of the PEPM / ICL superfamily members shows that a 
number of residues are stringently conserved among these proteins. The cofactors 
coordinate directly the Asp87 side chain (all residue numbering are according to DMML 
structure throughout this section unless indicated otherwise) and indirectly via three 
water molecules, the side chain carboxylic groups of Asp59, Asp89 and Glu116 (depicted 
for DMML in figure 1.3). These Mg2+/Mn2+ coordinating residues are invariant as 
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highlighted in red in figure 1.4. The Mg2+ cofactor coordinates one oxygen atom of the 
substrate C(1) carboxylate group and the C(2) α-oxygen atom, thereby serving as an 
electron sink in the stabilization of the oxyanion intermediate and/or transition state. The 
conserved capping loop residue Lys122 (except for OAD described in chapter 3) 
involved in loop opening and closure (Liu, Lu et al. 2004)  is stationed in the vicinity of 
Mg2+/Mn2+ in the closed gating loop conformation with two water molecules in between 
to reduce electrostatic repulsion. 
 Some of the residues that interact with the substrate are also con erved. Because 
the various substrates share a common pyruvyl/glyoxyl moiety, oxalate, an anolog of the 
shared pyruvyl adduct, is an inhibitor of all PEPM/ICL superfamily members.  The 
residues that interact with the conserved pyruvyl/glyoxyl moiety are highlighted in blue 
in figure 1.4. The inhibitor C(1)OO- carboxylate interacts with the Thr46 hydroxyl group 
(serine in the other lyases, PEP and PPHA ), and with an oxyanion hole formed by the 
backbone amides of Gly47 and Ala48 which are located at the N-terminus of a conserved 
short α-helix. One of the inhibitor’s C(2) oxygen atoms engages in an ionic interaction 
with the guanidinium group of Arg161 and is stationed in an oxyanion hole formed by 
Mn2+ and Arg161. Arg161 is an invariant residue that plays a key catalytic role.  
In addition to the residues that are conserved throughout the PEPM/ICL 
superfamily, there are signature residues that discriminates functional families within the 
superfamily and underscores the differences that makes each member uniquely tailored 
for its particular function. For example, the gating loops of the lyases, OAH, and 
CPEPM, carry a catalytic cysteine, whereas PEPM and PPHA contain asparagine and 
threonine, respectively.   
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Figure 1.4: Sequence alignment of the PEPM/ICL superfamily members. Conserved Mg2+/Mn2+ 
coordinating residues are highlighted in red, the substrate/inhibitor coordinating residues are 
colored blue and all other invariant residues are colored gray. 
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The sequence identity between members of the superfamily with different 
functions may be as low as ~20% and as high as ~60%. Low sequence id tity is often 
encountered within a superfamily; however, it is quite unusual for enzymes with 
sequence identity of 40% (viz. PDP and carboxyPEPM) or 57% (viz. OAH and DMML) 
to have different functions. This underscores the blurring of boundaries between function 
families and the uncertainties of database annotations. A phylogeny tree generated in our 
laboratory using enzymes of known structures and/or confirmed function as seed for 
multiple sequence alignment shows clear separation between several function groups 
(Fig. 1.5), yet it also reveals a region of ambiguity of function and regions where the 









Figure 1.5: Phylogeny tree of the PEPM/ICL superfamily. Adapted from (Liu, Lu et al. 2005) 
 
  The ICL and MICL enzymes form two well separated groups but the ICL2 type 
MICLs are contained within the ICL family cluster. There are differences in substrate 
binding motifs between ICL and MICL, which is evident from the structures of the two 
enzymes (Liu, Lu et al. 2005). The P-C bond breaking family including PEPM and PPHA
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is also well separated from other families. The cluster comprising the more distant 
transferases (PanB) which do not possess the gating loop, oligomerizes un quely into 
decamers, and differ in several key active site residues, is well separated from the rest of 
the enzyme clusters.  
The phylogeny tree revealed two distinct branches comprising proteins of 
unknown functions. One branch includes the Ps udomonas aeruginosa PA4872, the first 
protein I studied, which subsequently was shown by us to be a novel oxaloacet te 
decarboxylase (Narayanan, Niu et al. 2008). The crystal structure determination was 
crucial to function assignment because it provided the first clue that the catalytic 
mechanism of the enzyme involves an enolate intermediate and ruled out lyase activity 
involving a carbanion intermediate (Liu, Lu et al. 2005).  Chapter 3 provides a detailed 
account of the studies on this enzyme. The function of the second family cluster in the 
phylogeny tree remains unknown despite the recent structure report of one member (Liao, 
Chin et al. 2008), which contains an intrinsically bound ligand interpreted by the authors 
as α-ketoglutarate.  
 The family adjacent to MICL in the phylogeny tree includes enzymes with 
different functions despite the high sequence identity they share: CPEPM, PDP, and 
OAH. The second protein that I studied, 2,3-dimethylmalate lyase belongs to this clade. 
Before we began our studies, the protein was thought to be OAH because it exhibits 
~60% sequence identity to a confirmed OAH. Chapter 4 provides a complete account of 
these studies. Because of the diverse activities within this phylogeny clade, it may 
include members that have different, yet to be discovered functions, which is underscored 
by the discovery of DMML.  
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Chapter 2   X-Ray crystallography: Methodology 
 X-ray crystallographic methods were employed to determine the protein 
structures described in this thesis. The experimental and computational techniques used 
were summarized briefly in chapter 3 and 4 to enable other researchers reproduce the 
results. This chapter describes the procedures I employed in my studies in more detail. 
2.1   Crystallization of macromolecules 
 
 Despite much research to improve the predictability of protein crystal growth, the 
method remains empirical. However, extensive experience that has been accumulated 
over the years has led to the development of techniques that acceler te and automate the 
crystallization process. In my studies, I used the vapor diffusion method for 
crystallization. In the vapor diffusion method, small volumes of preci itant solution and 
protein are mixed together and the drop is equilibrated against a larger reservoir of 
solution containing just the precipitant solution. The method can be employed either with 
a hanging drop or a sitting drop setup. In the hanging drop method a drop containing the 
mixture of protein sample and precipitant solution is placed on a siliconized coverslip, 
flipped over to cover and seal the reservoir containing the precipitant solution. In the 
sitting drop method the crystallization solution is placed in the reservoir’s well, 
containing a bridge that holds the drop of the protein/precipitant mixture (Fig 2.1). The 
sitting drop arrangement is used in crystallization robots usually in a 96-well format. In 
most experiments the reservoir contains higher concentration of precipitant solution and 
equilibration leads to the increase in concentration of the protein solution, which leads to 












Figure 2.1: A typical sitting drop crystallization setup. 
Source:http://www.usm.maine.edu/chy/manuals/BiochemLab/Text/HdtXtals/images/wellplate.gif 
 
 In practice, initial screens of various preformulated conditions were tested 
employing both the hanging drops and sitting drops vapor diffusion methods using 
commercially available screens. Once a condition was identified that displayed crystals or 
the potential to develop crystals, crystal growth was optimized by fine sampling of 
various parameters that affect crystallization such as the precipitant concentration 
(ammonium sulphate,  various polyethylene glycols), pH of the solution, the temperature 
at which the crystallization trays were modified, and also the presence/absence of salt and 








Figure 2.2: (A) OAD – Mg2+ - oxalate crystals (B) DMML- Mn2+ - 3,3-difluorooxaloacetate crystals 
A B
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2.2   Data collection 
 
 X-rays generated from a copper source (CuKα wavelength is 1.5418Ǻ) were used 
on the home facility, but with the advent of tunable synchrotron X-rays, we exploited 
other wavelengths. To obtain an accurate structure, X-ray diffraction data collection 
should optimally cover the entire reciprocal space and extend to the maximum possible 
resolution characteristic of the particular crystal. The most efficient and universally 
employed method to acquire the diffraction data is the rotation or oscillation method. In 
this method the diffraction images (Fig. 2.3) are collected by rotating the crystal around a 
fixed axis in small continuous steps (0.25° - 0.5°) and the diffraction intensities are 
recorded on a detector.  
 
Figure 2.3: X-ray diffraction image of DMML- Mn2+- inhibitor complex crystal collected at 100K on 




 To reduce radiation damage, X-ray data collection is carried out at ~100K using a 
gaseous stream of cooled nitrogen. The crystals are first coated or soaked with 
cryoprotectants such as glycerol, ethylene glycol, or oil and then flash cooled. Optimal 
strategies for data collection are influenced by factors such as diffraction quality, cell 
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dimensions, crystal symmetry and crystal orientation relative to the incident X-ray beam. 
These parameters define the choice of exposure time and crystal to detector distance to 
obtain well separated diffraction spots in all crystal orientations and to maximize the 
signal to noise of the intensity measurements. 
Diffraction data for the DMML and wild-type PA4872 crystals were collected on 
the home facility consisting of Osmic Max-Flux monochromated X-rays generated by a 
Rigaku Micro Max 007 rotating anode equipped with a Rigaku R-AXIS IV++ detector. X-
ray diffraction data for the SeMet-containing Pa4872 protein crystal were collected in the 
synchrotron facility on the IMCA-CAT 17-ID beam line at the Advanced Photon Source 
(Argonne National Laboratory, Argonne, IL) utilizing three wavelengths for a MAD 
experiment (discussed later). 
2.3 Data  processing 
 
 The X-ray diffraction images are used to obtain a set of indices (hkl) and their 
intensities I(hkl) along with the intensity errors σI(hkl). Initially, the diffraction images 
are indexed by identifying a limited number of diffraction spots. The spot positions are 
used to deduce the crystal unit cell parameters and orientation with respect to the 
laboratory frame of reference by a least squares procedure. The lattic with highest 
symmetry that fits the reference spots with the lowest residual is selected. This is 
followed by the refinement of crystal and detector parameters and prediction of the 
positions of all diffraction spots in all images. The intensity of each of the diffracted spots 
is then integrated and corrected for background noise and systematic errors (polarization 
and Lorentz factor). The images are scaled using reflections that are measured multiple 
times to maximize the agreement between their intensity values. The structure factor 
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amplitudes are derived from the relationship: IF =  where, F is the structure factor 










where, V is the volume of the unit cell, fj is the scattering factor of atom j, lkhh ,,=  are 
the miller indices of a reflection, zyxx ,,=  are the fraction coordinates of atom j in real 
space and the summation is over all atoms 1 to N. 
2.4 The Phase Problem 
 
The measured intensities provide the structure factor amplitudes. However, 
structure factors are vectors and the phases that are essential for calculating the electron 
density map are lost when deriving the amplitudes from the intensities. Hence, the phases 
must be extracted through other means. Various methods are employed to obtain phases 
including direct methods, molecular replacement (MR), multiple isomorphous 
replacement (MIR) and multiwavelength anomalous diffraction (MAD). When there are 
problems of noise or unisomorphism, more than one of these methods may be combined 
to obtain the best possible phases. The following sections describe the MR and MAD 
methods as practiced in my studies. 
2.4.1   Molecular replacement (MR) 
 
 MR is used to solve the phase problem when a closely related structure is 
available. Usually, but not always, this entails high sequence identity with the sequence 
of the protein of interest. The technique is now widely used because the PDB often 
contains a structure that can serve as a MR search model. In MR, the model structure is 
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oriented and positioned in the crystal cell so that the calculated diffraction best matches 
the observed diffraction. This is done in two separate steps: the rotation search and the 
translation search (Rossmann and Blow 1962) and in practice the calculations are carried 
out in reciprocal space. Once the position of the molecule in the cell is defined, the initial 
map is calculated using the experimentally observed amplitudes an  the phases generated 
using the model structure as it is placed in the cell. The resulting electron density map is 
then used to improve the model by modifying incorrectly positioned amino acid residues. 
The MR program I employed to obtain phases for the two DMML structu es was 
PHASER (McCoy, Grosse-Kunstleve et al. 2007). The program incorporates a 
maximum-likelihood treatment that calculates the probability that t e observations will 
be made given a particular model. The model with the highest likelihood is then chosen 
as the one that best accounts for the observations (Read 2001).  
2.4.2 Multiwavelength anomalous diffraction 
 
The Multiwavelength anomalous diffraction (MAD) technique is employed when 
a heavy atom with large anomalous signal is present in the crystal, which is often 
implemented in protein crystallography by incorporating selenium in the place of sulphur 
in methionine residues. In MAD, the wavelength is tuned to the absorption edge of the 
heavy atom to maximize the anomalous scattering signal arising from the electrons 
around the heavy atoms that absorb the incident X-rays and diffract with a phase 
difference (Hendrickson, Smith et al. 1985). Because of the phase difference, the 
amplitudes of the two reflections that form a Bijvoet pair are not equal to one another, 
which facilitate phase determination. The initial phases are obtained by first locating the 
positions of the heavy atoms and calculating the phases by a derivation analogous to that 
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used in MIR. It should be noted that there are actually two possibilities for the initial 
phases +φ and –φ. This phase ambiguity is solved by collecting an additional dataset at a 
wavelength close to the absorption edge of the heavy atom in the crystal where the 
anomalous signal is maximized. In solving the PA4872 (OAD) structure, I used the 
program SHELXD (Schneider and Sheldrick 2002) to locate the heavy atom sites and the 
program MLPHARE (Otwinowski 1991) to refine those sites and calculate the initial 
phases. The phases were further improved by density modification methods (Cowtan 
1994), and these improved phases were used to calculate the initial electron density map. 
2.5 Electron density calculation and model building 
 











),,( πρ  
where, V is the volume of the unit cell, hklF  is the structure factor (amplitude and 
phase), h  is the miller indices (h,k,l), x  is the fraction coordinates (x,y,z) and the 
summation is over h  from -∞ to +∞. The coefficients 2Fo-Fc and calculated phases are 
used to calculate the electron density map where Fo and Fc are the observed and calculated 
structure factors. The electron density map of a section of the OAD structure is shown in 
figure 2.4 (A). 
An initial model is built into the calculated electron density map using interactive 
graphics workstation. Figure 2.4(B) depicts the OAD polypeptide segment that was built 
into the electron density map shown in figure 2.4(A). The initial model was built 
automatically for the OAD structure using the programs Solve/ Resolve (Terwilliger and 
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Berendzen 1999; Terwilliger 2003), whereas the DMML initial model was obtained from 
the MR solution and required only placement of sidechains and modifications in regions 
that differed from the search model. The manual model rebuilding for the OAD structures 
and DMML structures were carried out using the graphics programs “O” (Jones, Zou et 
al. 1991)  and COOT (Emsley and Cowtan 2004), respectively. 
 
Figure 2.4: (A) The 2Fo-Fc electron density map of OAD at 1.9Å resolution. The coefficients 2Fo-
Fc and calculated phases are used. (B) Polypeptide chain built into the electron density cage of 
OAD. The polypeptide chain in this region adopts an α-helical conformation 
 
2.6 Structure refinement 
 
The initial model is usually inaccurate and needs to be improved using iterative 
steps of refinement and model modification on an interactive graphic workstation. The 
computer refinement program shifts atom positions and temperature f ctors to achieve 
better agreement between the observed and calculated structure fao s. During the latter 
stages of refinement, water molecules, metal ions and other ligands (substrates/inhibitors, 
glycerol) are added into the electron density map. The resulting model is inspected 
(A) (B) 
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together with the new electron density map and a further round of refinement is carried 
out. This continues until the correlation between the observed and calculated structure 
factors is maximized. The agreement is measured by the R-factor and Rfree values. R-














Rfree is calculated from a subset (5-10%) of reflections that were not included in 
refinement. It is important to assure that the number of variables that are being refined 
(x,y,z, temperature factors, occupancies) does not exceed the number of observations, 
otherwise the problem is underdefined. Because of the limited diffraction resolution of 
most protein crystals, the number of reflections measured is almost always insufficient. 
Thus, geometrical restraints such as bond lengths, bond angles, chirality and planarity are 
included to increase the number of observations. The weight given to the geometrical 
restraints are calculated so that the root mean squares deviations re comparable to those 
found in small molecule structures determined at atomic resolution where no restraint are 
used during refinement. The refinement programs I used (CNS (Brunger, Adams et al. 
1998) and REFMAC (Murshudov, Vagin et al. 1997)) both employed the maximum 
likelihood weighting where the weight is chosen according to the refinement target 
function and the current model.  
2.7 Structure validation 
 
Upon completion of the refinement, the quality of the structure is analysed. The 
program PROCHECK (Laskowski, Moss et al. 1993) was used to verify the stereo 
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chemical quality of the protein structures. The output consists of a detaile  listing of 
parameters and their graphical representation, for each residue. These include the 
Ramachandran plot, deviation from bond angles and bond length, chirality checks, side 
chain dihedral angles and short contacts. The program compares and assesses the 
structure quality with respect to other structures at comparable esolution. Outstanding 
outlier regions are inspected to identify the source of the error and corrected. The refined 
structure (both the coordinates and the structure factor) is then submitted to the Protein 

















Chapter 3   Structure and function of PA4872 from 
Pseudomonas aeruginosa,  novel oxaloacetate decarboxylase 
from the PEP mutase / isocitrate lyase superfamily  
3.1   Abstract 
 
Pseudomonas aeruginosa PA4872 was identified by sequence analysis as a structurally 
and functionally novel member of the PEP mutase/isocitrate lyase sup rfamily and 
therefore targeted for investigation. Substrate screens ruled out overlap with known 
catalytic functions of superfamily members. The crystal structure of PA4872 in complex 
with oxalate (a stable analog of the shared family α-oxyanion carboxylate 
intermediate/transition state) and Mg2+ was determined at 1.9 Å resolution. As with other 
PEP mutase/isocitrate lyase superfamily members, the protein assembles into a dimer of 
dimers with each subunit adopting an α/β barrel fold and two subunits swapping their 
barrel’s C-terminal α-helices. Mg2+ and oxalate bind in the same manner as observed with 
other superfamily members. The active site gating loop, known to play a c talytic role in 
the PEP mutase and lyase branches of the superfamily, adopts an open conformation. The 
Nε of His235, an invariant residue in the PA4872 sequence family, is oriented towards a 
C(2) oxygen of oxalate analogous to the C(3) of a pyruvyl moiety. Deuterium exchange 
into α-oxocarboxylate-containing compounds was confirmed by 1H-NMR spectroscopy. 
Having ruled out known activities, the involvement of a pyruvate enolate intermediate 
suggested a decarboxylase activity of an α-oxocarboxylate substrate. Enzymatic assays 
led to the discovery that PA4872 decarboxylates oxaloacetate (kcat = 7500 s
-1 and Km = 
2.2 mM) and 3-methyloxaloacetate (kcat = 250 s
-1 and Km = 0.63 mM). Genome context of 
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the fourteen sequence family members indicates that the enzyme is us d by select group 
of Gram-negative bacteria to maintain cellular concentrations f bicarbonate and 
pyruvate; however the decarboxylation activity cannot be attributed to a pathway 
common to the various bacterial species.  
3.1 Introduction 
 
The studies described in this paper were carried out to determine the biochemical 
function of the hypothetical protein PA4872 from Pseudomonas aeruginosa. PA4872 is a 
member of the PEP mutase/isocitrate lyase (PEP mutase/isocitrate lyase) superfamily 
(Liu, Lu et al. 2005). Enzymes of the PEP mutase/isocitrate lyasesup rfamily catalyze 
either P-C or C-C bond formation/cleavage. The P-C bond modifying enzymes that have 
been characterized to date include PEP mutase, carboxyPEP mutase and 
phosphonopyruvate hydrolase (reactions 1-3 of Figure 3.1). Enzymes known to act on C-
C bonds include 5, 10-methylenetetrahydrofolate:3-methyl-2-oxobutanoate 
hydroxymethyl transferase (MOBH), isocitrate lyase, 2-methylisocitrate lyase, the plant 
petal death protein (a broad specificity 2-alkyl malate lyase having an additional 
oxaloacetate hydrolase activity) and fungal oxaloacetate hydrolase (reactions 4-7 of 
Figure 3.1).  A detailed introduction to the PEPM /ICL superfamily is given in Chapter 1. 
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Figure 3.1. The reactions catalyzed by the PEP mutase/isocitrate lyase superfamily. The 
reactions are depicted to occur stepwise with the formation of reaction intermediates (shown in 
brackets). The reactions might be concerted in which case the transition state will resemble the 
intermediate.   
 
To discover novel catalytic functions within the PEP mutase/isocitrate lyase 
superfamily we have focused our attention on the residue usage and the length of the 
gating loop possessed by members having unknown function. An alignment of family 
sequences identified PA4872 as a representative of a unique clad containing eight 
members at the time of analysis (now 14 members) and having a novel sequence for the 
active site gating loop (Liu, Lu et al. 2005). We set forth to discover th  reaction 
catalyzed by PA4872 by employing a functional genomic approach that combines 
structure determination, activity screening and genome context neighbor analysis. Here 
we present the results, which show that PA4872 is an oxaloacetate dec rboxylase, used 
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primarily by Pseudomonads. Inspection of genome contexts led us to speculate that the 
enzyme is employed by different bacterial species to maintain pyruvate and/or 
bicarbonate cellular levels in a variety of pathways.  
3.3   Materials and methods 
3.3.1   Preparation of recombinant wild-type PA4872 
 
PA4872 was amplified from P. aeruginosa using Pfu Turbo DNA polymerase 
(Stratagene), genomic DNA, and oligonucleotide primers with restriction sites for NdeI 
and BamHI. The purified product was ligated to a NdeI- and BamHI-cut pET3c vector 
(Novagen). The resulting clone, PA4872-pET3c, was used to transform E. coli BL21 
(DE3) cells (Novagen). The gene sequence was verified by DNAsequencing carried out 
at the Center for Genetics in Medicine, University of New Mexico School of Medicine. 
Transformed E. coli cells were grown to OD600nm ~ 0.8 at 25 °C in Luria broth (LB) 
media containing 50 µg/ml carbenicillin. Overexpression was induced with 0.4 mM 
isopropyl-D-thiogalactopyranoside (IPTG) at 25 oC. The cells were harvested by 
centrifugation at 6500 rpm (7,808g) for 15 min at 4 °C and suspended in 150 mL of lysis 
buffer (50 mM Na+Hepes (pH 7.5), 5 mM DTT, 1 mM EDTA,  
1 mM benzamide hydrochloride, 0.05 g/L trypsin inhibitor, 1 mM 1,10-phenanthroline, 
and 0.1 mM phenylmethylsulphonylfluoride). Cells were lysed using a French press and 
then centrifuged for 60 min 15 min at 4 °C. The protein of the supernatant was 
fractionated by (NH4)2SO4 induced precipitation and harvested by centrifugation. The 
PA4872-containing fraction (40-60 % saturated (NH4)2SO4) was dissolved in buffer A 
(50 mM triethanolamine (pH 7.5), 5 mM MgCl2 and 0.5 mM DTT), and then dialyzed 
against 4 x 1 L buffer A at 4 oC before loading onto a 3.5 x 60 cm DEAE-cellulose 
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column. The column was washed with 1 L buffer A and then eluted with a 1.4 L linear 
gradient of KCl (0 – 0.8 M) in buffer A. The chromatography was monitored by 
measuring the absorbance of the eluted fractions at 280 nm and by carrying out SDS-
PAGE analysis.  The desired fractions (eluted at ~ 0.4 M KCl) were combined, mixed 
with (NH4)2SO4 to 20% saturation, and loaded onto a 3 x 30 cm phenyl Sepharose 
column equilibrated with 20% saturated (NH4)2SO4 in buffer A. The column was washed 
at 4 oC with 500 mL of (NH4)2SO4 (20% saturation) in buffer A and then eluted with a 
700 mL linear gradient of (NH4)2SO4 (20% - 0% saturation) in buffer A. The desired 
fractions (eluted at 0% of ammonium sulfate) were combined, mixed with (NH4)2SO4 to 
25% saturation, and loaded onto a 3 x 30 cm butyl Sepharose column equilibrated with 
25% saturated (NH4)2SO4 in buffer A. The column was washed at 4 
oC with 500 mL of 
25% saturated (NH4)2SO4 in buffer A and then eluted with a 800 mL linear gradient of 
(NH4)2SO4 (25% - 0% saturation) in buffer A. The desired fractions (eluted a ~12% 
saturated (NH4)2SO4) were combined and concentrated to 15 mL using an Amicon 
concentrator (Amicon), dialyzed against 4 × 1 L buffer A, and then concentrated to 35 
mg/mL using MACROSEP 10K OMEGA (centrifugation at 6500 rpm). The purified 
protein (yield 4.4 mg/gm wet cells) was shown to be homogeneous by SDS-PAGE 
analysis and stored at – 80 oC. The molecular mass measured by TOF MS-ES mass 
spectrometry (University of New Mexico Mass Spectrometry Lab) is 31321 Da, identical 
to the protein’s theoretical molecular mass.  
3.3.2 Preparation of selenomethionine containing PA4872 
 
For the preparation of selenomethionine (SeMet)-containing protein, E. coli BL21 
(DE3) cells transformed with the PA4872-pET3c vector were grown in minimal media 
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containing SeMet instead of methionine. The overexpression and purification protocols 
used are the same as those employed for the production of the wild type protein. 
3.3.3 Preparation of PA4872 site directed mutants 
 
Site-directed mutagenesis was carried out by using the Quikchange method and 
Turbopfu polymerase. The plasmid PA4872-pET3c was used as the template for th PCR 
amplification. The mutant proteins were purified using the same protocol as described for 
the wild-type recombinant enzyme. The homogeneity (>90%) of the purified mutant 
proteins was confirmed by SDS-PAGE analysis. Mutant protein yield: ~3 mg/gm of wet 
cells.  
3.3.4 PA4872 crystallization and data collection 
 
Wild-type PA4872 was crystallized in hanging drops by the vapor diffusion 
method at room temperature. The drops contained equal volumes of reservoir olution 
and 10 mg/mL protein in 5 mM MgCl2, 5 mM oxalate and 10 mM Na
+Hepes (pH 7.0). 
The reservoir solution contained 18% polyethylene glycol 3350, 20% glycerol and 0.1 M 
MES (pH 6.0). Crystals appeared within two days. SeMet-containing PA4872 was 
crystallized in sitting drops by the vapor diffusion method at room te perature. Aliquots 
of 10 mg/mL protein in 5 mM MgCl2, 5 mM phosphonopyruvate and 10 mM Na
+Hepes 
(pH 7.0) were mixed with equal volumes of reservoir solution containing 12% 
polyethylene glycol 20,000 and 0.1 M MES (pH 6.0).  
X-ray diffraction data for a SeMet-containing protein crystal were collected at 
IMCA-CAT 17-ID beam line at the Advanced Photon Source (Argonne National 
Laboratory, Argonne, IL). Prior to data collection, crystals were transferred to mother 
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liquor containing 25% glycerol and flash-cooled in liquid propane cooled by liquid 
nitrogen. Multiple Anomalous Diffraction (MAD) data at 2.2Ǻ resolution were collected 
from a single crystal at three different wavelengths (Se absorption edge inflection, peak, 
and high energy remote wavelength). 
Table 3.1.  Data collection statistics 
Sample Wild-type Se-Peak Se-Inflection Se-Remote 
Wavelength (Å) 1.0000 0.97944 0.97954 0.96485 
Space Group C2 C2 
















No. observationsa 522013 526067 525654 526511 
No. unique reflections 159433 190525 190709 190732 
Completeness (%) 97(77.8) 91.8(94.7) 91.8(94.6)  91.6(94.3)  
R
merge 
b 0.054(0.358)  0.042 (0.230)  0.042 (0.235)  0.042 (0.242)  
Mean I/σ(I)  10.9(2.1)  39.1 (7.8)  21.3(4.1)  15.2(2.7)  
Redundancy  3.3(2.1) 2.8(2.7) 2.8(2.7)  2.8(2.7)  
a Bijvot pairs are separated in the MAD experiment. 




Diffraction data for a wild-type PA4872 crystal were collected on the home 
facility using a Osmic Max-Flux monochromated X-rays generated by a Rigaku Micro 
Max 007 rotating anode equipped with a Rigaku AXIS IV++ detector. Data were 
processed with Crystal Clear/d*trek ((Pflugrath 1999), Rigaku/MSC, the Woodlands, 
TX).  Data collection statistics are shown in Table 3.1.
3.3.5 Structure determination and refinement 
 
Selenium sites were identified using the computer program SHELXD (Schneider 
and Sheldrick 2002). Initial phases were calculated using the program MLPHARE 
(Otwinowski 1991) in CCP4 (Cowtan 1994). Phase improvement by density modification 
followed (Cowtan 1994). The initial model was built automatically with the 
Solve/Resolve programs (Terwilliger and Berendzen 1999; Terwilliger 2003). Further 
building of side chains and model modification were done manually on a Silicon 
Graphics workstation using the graphics program “O” (Jones, Zou et al. 1991). After 
adding the side chains to one molecule, the asymmetric unit model was generated by 
applying the non-crystallographic symmetry operators.  
Refinement was carried out using the data collected from the wild-type PA4872 
crystal, which diffracted to higher resolution (1.9 Ǻ) than the SeMet-containing protein 
crystal. CNS (Brunger, Adams et al. 1998) was used initially. Simulated annealing at 
2500K was followed by alternating positional and individual temperature factor 
refinement cycles. As the refinement advanced, REFMAC (Cowtan 1994; Murshudov, 
Vagin et al. 1997) was used. Progress of the refinement was evaluated by the 
improvement in the quality of the sigma(a)-weighted 2Fobs - Fcalc and Fobs - Fcalc electron 
density maps (Read 1986), and the reduction of the conventional R-factor and Rfree 
 29
values. Mg2+, oxalate and water molecules were added gradually as the model iproved. 
They were assigned in the Fobs - Fcalc difference Fourier maps with a 3σ cutoff level for 
inclusion in the model. The refinement statistics are given in Table 3.2. 
Table 3.2. Refinement statistics 
Resolution (Å) 38.5 - 1.9 
No. reflections refined 143540 
No. reflections not refined (10%) 15883 
Rwork/Roverall/ Rfree
 a  0.195/0.202/0.257 
No. Protein atoms 12767 
No. Mg2+-oxalate 6 
No. water molecules 1728 
RMSD from ideal geometry 
           Bonds (Å) 0.019 
           Angles (°) 1.7 
Mean B value (Å)2 34 
a R  = ∑hkl | |Fo| – |Fc| | / ∑hkl |Fo|, where Fo and Fc are the observed and calculated 
structure factors, respectively. Rwork corresponds to the reflections used in refinement, 
Rfree refers to randomly selected reflections omitted from the refinement, and Roverall 
corresponds to all reflections. 
 
3.3.6   Modeling of the gating loop-closed conformation 
 
A model of the active-site gating loop in a closed conformation was generated 
based on the Cα trace of the 2-methylisocitrate lyase loop. Side chains were added 
manually using the program “O”. Energy minimization of the modeled loop was carried 
out in CNS, keeping the remainder of the molecule fixed. 
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3.3.7   Structure analysis 
 
Superposition of structures was carried out within the program ‘O’ (Jones, Zou et 
al. 1991). The stereochemical quality of the structure was assessed with the program 
PROCHECK (Laskowski 1993). The programs PyMOL (DeLano 2002) and CCP4mg 
(Potterton, McNicholas et al. 2002; Potterton, McNicholas et al. 2004) were used for 
structure depictions. The program Voidoo was used to calculate the ac iv  site cavity 
(Kleywegt and Jones 1994).   
3.3.8 Activity Assays for Substrate Screening 
 
The catalyzed conversion of phosphonopyruvate to PEP was tested using the 
pyruvate kinase (PK)/ADP and lactate dehydrogenase (LDH)/NADH coupling system to 
convert PEP to lactate with the coupled conversion of NADH to NAD+. The reaction 
solution (1 mL) contained 17 µM PA4872, 1 mM phosphonopyruvate, 5 mM MgCl2, 20 
units/mL PK, 20 units/mL LDH, 2 mM ADP, and 0.2 mM NADH in 50 mM K+Hepes 
(pH 7.5 and 25°C). The absorbance of the solution was monitored at 340 nm (∆ε= 6.2 
mM-1 cm-1) over a 30 min time period. 
The conversion of phosphonopyruvate to pyruvate was monitored using the 
LDH/NADH coupled assay. The reaction solution (1 mL) contained 17 µM PA4872, 1 
mM phosphonopyruvate, 5 mM MgCl2, 20 units/mL LDH, and 0.2 mM NADH in 50 mM 
K+Hepes (pH 7.5 and 25°C). The absorbance of the solution was monitored at 340 nm 
(∆ε = 6.2 mM-1 cm-1) over a 30 min time period.  
The lyase activity with the reactants (R)-malic acid, (S)-malic acid, (2R,3S)-
isocitric acid, threo-(2R,3S:2S,3R)-2-methylisocitrate, 3-butylmalate, 2R-citramalate, 2S-
citramalate, 2R-ethyl-3S-methylmalate and (2R,3S)-dimethylmalate was measured at 
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25°C using the LDH/NADH coupled assay. The reaction solutions (1 mL) initially 
contained 1 mM substrate, 17 µM PA4872, 5 mM MgCl2, 20 units/mL LDH (except for 
2R-ethyl-3S-methylmalate, for which 400 units/mL LDH was used), and 0.2 mM NADH 
in 50 mM K+Hepes (pH 7.5 and 25°C). The absorbance of the solution was monitored at 
340 nm (∆ε= 6.2 mM-1 cm-1) over a 30 min time period. Control reactions not including 
PA4872 were run in parallel. 
The conversion of carboxyPEP to phosphinopyruvate was tested using the malat
dehydrogenase/NADH coupled assay.  The reaction solution (1 mL) contained 17 µM 
PA4872, 1 mM carboxyPEP, 5 mM MgCl2, 20 units/mL malate dehydrogenase, and 0.2 
mM NADH in 50 mM K+Hepes (pH 7.5 and 25°C). The absorbance of the solution was 
monitored at 340 nm (∆ε = 6.2 mM-1 cm-1) over a 30 min time period. 
3.3.9 PA4872 catalyzed enolization of α-keto acids 
 
The enolization rates of pyruvate, 2-keto-4-methyl pentanoate “α-
ketoisocaproate”, 2-keto butanoate “α-ketobutyrate”, 2-keto pentanoate “α-ketovalerate”, 
2-keto-3-methyl butanoate “α-ketoisovalerate” and 2-keto-3-methyl pentanoate “α-keto-
β-methyl-valerate” catalyzed by PA4872 were determined by monitori g the exchange of 
the C(3) hydrogen atom(s) in buffered D2O using 
1H-NMR techniques. The solutions 
contained 100 mM Tris-d11 (pH 7.5), 60 mM substrate, and 5 mM MgCl2 in a total 
volume of 0.5 mL. Assays were initiated by the addition of PA4872 (1.3 µM for α-
ketovalerate, 25 µM for pyruvate and α-ketobutyrate, 74 µM for α-ketoisovalerate and α-
keto-β-methyl-valerate). 1H-NMR spectra were recorded at 20 °C at 500 MHz with a 
Bruker Avance 500 NMR instrument spectrometer, using 10 mM 2-methyl-2-propan(ol-
d) as the internal standard. The control reactions, which did not contain enzyme, were 
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carried out in parallel. The rates of α-ketovalerate enolization catalyzed by the H235A (8 
µM) and H235Q (10 µM) PA4872 mutants were measured using the same protocol as 
were the rates of pyruvate enolization catalyzed by phosphonopyruvate hydrolase (5 
µM), petal death protein (4 µM) and PEP mutase (5 µM).  
The observed rate constant for catalyzed proton exchange (kenol) was calculated 
from the 1H-NMR spectra using equation 1 where At/A0 is the ratio of the C(3) proton 
peak areas determined at time “t” and at t = 0, [S0] is the initial substrate concentration 
and [E] is the enzyme concentration. 
                                                  kenol  = -(ln(At/A0))[S0] / t[E]                                      (1)
 
3.3.10 13C-NMR analysis of PA4872 catalyzed decarboxylation of oxaloacetate  
 
The 13C-NMR spectra were recorded at 25 oC by using a Bruker Avance 500 
NMR spectrometer. Methanol served as an internal standard (49 ppm). Following a 30 
min incubation period of a solution initially containing 31 µM PA4872, 600 mM 
oxaloacetate, 5 mM MgCl2 in deionized water at 25 
oC (adjusted to pH 7.5 with aqueous 
NaOH), the PA4872 was removed by filtration using a centricon device. D2O was added 
to the filtrate to a final concentration of 10% (v/v). The 13C-NMR spectra of oxaloacetate, 
pyruvate, oxalate and bicarbonate in aqueous solution with 5 mM MgCl2 (pH 7.5) were 
measured at 25oC. Oxaloacetate signals appeared at 200.5 ppm (C(2)), 174.8 ppm (C(4)), 
168.4 ppm (C(1)), 98.3 ppm (C(3)). The pyruvate signals appeared at 205.2 ppm (C(2)), 




3.3.11 Oxaloacetate and 3-methyloxaloacetate decarboxylation assays 
 
Direct Assay: the wild-type and mutant PA4872-catalyzed oxaloacetate decarboxylati n 
reactions were monitored by using the continuous spectrophotometric assay for 
oxaloacetate consumption (decrease in solution absorbance at 255 nm; ∆ε = 1.1 mM-1) 
(Lenz, Wunderwald et al. 1976). Reactions (0.25 mL) were carried out in quartz cells of 
0.1 cm path length at 25 oC. Reaction solutions initially contained oxaloacetate, 5 mM 
MgCl2 and 50 mM K
+Hepes (pH 7.5). Coupled assay: the PA4872 catalyzed 
decarboxylation reactions of oxaloacetate or 3-methyloxaloacetate were monitored at 340 
nm (∆ε = 6.2 mM-1 cm-1) using a coupled assay for pyruvate or α-ketobutyrate formation. 
Reactions (1 mL volume) were carried out in quartz cells of 1 cm path length at 25 oC. 
Assay solutions contained oxaloacetate or 3-methyloxaloacetate, 10 U lactate 
dehydrogenase, 0.2 mM NADH, 5 mM MgCl2 and 50 mM K
+Hepes (pH 7.5). 
3.3.12 Steady-state kinetics analysis 
 
The steady-state kinetic parameters (Km and kcat) were determined from the initial 
velocity data measured as a function of oxaloacetate concentration (varied from 0.5 to 5-
fold Km). The initial velocity data were fitted to Equation 2 with KinetAsystI: 
V0 = Vmax[S]/( Km +[S])     (2) 
where [S] is the substrate concentration, V0 is the initial velocity, Vmax is the maximum 
velocity, and Km is the Michaelis-Menten constant. The kcat value was calculated from 
Vmax and the enzyme concentration using the equation kcat = Vmax/[E], where [E] is the 
PA4872 subunit molar concentration in the reaction.  
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3.3.13 pH rate profile determination 
 
The steady-state rate constants kcat and kcat/Km were measured as function of 
reaction solution pH for PA4872-catalyzed oxaloacetate decarboxylation. The reactions 
were monitored using the direct assay (see above). Reaction solutions initially contained 
5 mM MgCl2, various concentrations of oxaloacetate (0.5-5 Km) and PA4872 in the 
following buffers: (pH 5.0-5.5) 50 mM MES, (pH 5.5-8.0) 25 mM K+Hepes and 25 mM 
MES, (pH 8.0-9.0)  25 mM K+Hepes and 25 mM TAPS, (pH 9.0-9.5)  25 mM TAPS and 
25 mM CAPSO. 
3.3.14 1H-NMR  analysis of PA4872 catalyzed  3-methyloxaloacetate 
decarboxylation 
 
 The reaction solution initially contained 5 mM MgCl2, 10 mM 3-
methyloxaloacetate, 6 nM PA4872, and 1 mM sodium acetate (internal standard) in 50 
mM KH2PO4 (pH 7.0, 20 °C). 
1H-NMR spectra were recorded at 20°C with a Bruker 
Avance 500 NMR spectrometer. The decarboxylation reaction was monitored by 
measuring the disappearance of the C(3)CH3 
1H-NMR signal. The two control reactions, 
one which lacked PA4872, and the other both PA4872 and MgCl2, were carried out in 
parallel.  
The steady-state kinetic constant for catalyzed decarboxylation (kcat) was 
calculated from the 1H-NMR spectral data using equation 3, where At/A0 is the ratio of 
the C(3) proton peak areas determined at time “t” and at t = 0, [S0] is the initial substrate 
concentration and [E] is the enzyme concentration.  
                                                kcat  = -(ln(At/A0))[S0] / t[E]                                      (3) 
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3.3.15 Inhibition constant determination 
 
The competitive inhibition constant Ki was determined for 2,2-
difluoroxaloacetate, pyruvate, oxalate, α-ketovalerate, acetopyruvate, and 
phosphonopyruvate vs. oxaloacetate by fitting initial velocity data (obtained using the
direct assay described above) to equation 4 with KinetAsystI 
                                V0=Vmax[S]/[Km(1 + [I]/Ki) + [S]]                                        (4) 
Reaction solutions (0.25 mL) initially contained 0.8-8 mM oxaloacetate, 2 ×10-3 µM 
PA4872, 5 mM MgCl2 and  3,3-difluoroxaloacetate (0, 0.8, 1.6 mM), pyruvate (0, 4, 8, 
16 mM), oxalate (0, 0.1, 0.2 mM), α-ketovalerate (0, 8, 16 mM), acetopyruvate (0, 2, 4 
mM), or phosphonopyruvate (0, 4, 8 mM) in 50 mM K+Hepes (pH 7.5, 25 °C).  
3.4   Results and discussion 
 
A complete assignment of a biological function to an “unknown” member of an 
enzyme superfamily requires the identification of the type of chemical reaction that it 
catalyzes, the range of reactants that it can efficiently transform, and the metabolic 
context(s) of the reaction(s) in the organism. The active sitesof the members of an 
enzyme superfamily have in common a conserved catalytic scaffold that positions core 
residues that function in stabilization of a common intermediate and/or transition state. 
Families within a superfamily diversify by acquiring active sit  residues that expand the 
range of chemical reactions. Accordingly, the core residues that s abilize the α-oxyanion 
intermediate shared by the PEP mutase/isocitrate lyase superfamily members are 
conserved in the PA4872 amino acid sequence. Key to the discovery of the structure of 
the intermediate stabilized by PA4872 is the determination of the spatial disposition of 
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the diversity residues within the catalytic site. Thus, our first step in the PA4872 function 
assignment was the determination of the PA4872 X-crystal structure.  
3.4.1   Overall structure  
 
The PA4872/Mg2+-oxalate crystal structure, refined at 1.9 Ǻ resolution, includes 
six molecules in the asymmetric unit. Four molecules denoted A-D form a tetramer 
(Figure 3.2A), the biological relevant assembly, and two molecules (E and F) form a 
dimer, which together with a crystallographic symmetry related dimer comprises another 
tetramer. The model includes residues 4-284 of molecule A except that no electron 
density is associated with the side chain of residue 128. Molecule B includes residues 4-
128, and 130-285. Molecule C includes residues 4-255, and 259-284, with no electron 
density for the side chain of residue 128 is disordered. Molecule D includes residues 4-
126 and 129-284. Molecule E includes residues 4-285 with no electron density for the 
side chain of residue 273. Molecule F includes residues 4-284 with no electron density 
for the side chains of residues 128 and 259. The model includes 1728 water molecules. 
The tetramers obey 222 symmetry and pack into a dimer of dimers. The root mean-square 
deviation (rmsd) between Cα atoms of the molecules in the asymmetric unit is on 
averages 0.2 Å. Each molecule contains Mg2+ and an oxalate. All backbone torsion angle 
values are within the allowed regions of the Ramachandran plot, and the bond lengths 
and bond angles are well within the range observed in crystal structures of small 










Figure 3.2 – Overall fold of PA4872. (A) The tetramer structure highlighting each subunit in 
different color. Mg2+ is depicted as yellow sphere and oxalate as stick models with an atomic 
coloring scheme: Carbon - green, oxygen – red. (B) Superposition of the PA4872 (gold and 
salmon) and 2-methylisocitrate lyase (purple) monomers, illustrating the different paths of the C-
terminal chains. 
 
PA4872 adopts the α/β barrel fold characteristic of the PEP mutase/isocitrate 
lyase superfamily, in which the eighth α-helix of a subunit is swapped with that of an 
adjacent subunit. The gating loop adopts an open conformation and the active site, 
containing Mg2+ and oxalate (Figure 3.2B), is solvent accessible. PA4872 differs from 
other superfamily members in the C-terminus following the swapped α-helix. Whereas 
the C-terminus of all other superfamily members traverses the active site of the partner 
subunit, in PA4872 the polypeptide chain turns back after the swapping of the helix and 
traverses its own active site (Figure 3.2B).  
3.4.2 Active-site 
 
As with other α/β barrel enzymes (Branden 1980), the active site is located at the 
C-terminal end of the barrel’s β-strands. Mg2+ and oxalate bind in a highly polar cavity 
(Figure 3.3). Mg2+ coordinates the C(1)O and C(2)O oxygen atoms of oxalate, the Asp88 
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carboxylate and 3 water molecules. The 3 water ligands engage in hydrogen bond 
interactions with the side chain carboxylic groups of Asp61, Asp90, Glu117, and Asp88. 
The oxalate C(1)OO- carboxylate interacts with the Ser50 hydroxl group (2.5 Å), and 
with an oxyanion hole formed by the backbone amides of Gly49 and Ser50 (3.5Å and 
3.1Å, respectively). Gly49 and Ser50 are located at the N-terminus of a short α-helix, 
suggesting that the helix dipole also contributes to substrate binding. The oxalate 
C(2)OO- engages in an ionic interaction with the guanidinium group of Arg159 (3.1 Å). 
No restraints were imposed on the planarity of the oxalate during the refinement. The six 
molecules in the asymmetric unit exhibit on average a 19º departure f om planarity 
(referring to the C(1)-C(2) torsion angle). This appears to be a significant distortion but 
should be taken with caution because the oxalate crystallographic temperature factors are 
relatively high at 42 Å2.  The mode of oxalate interaction with the protein groups is the 
same as observed for the crystal structures of PEP mutase (Huang, Li et al. 1999) and 
phosphonopyruvate hydrolase (Chen, Han et al. 2006), and comparable to the mode of 
pyruvate interaction with protein groups observed for the crystal structure of 2-
methylisocitrate lyase (Liu, Lu et al. 2005). The arginine, oxyanion hole and the Mg+2 
binding residues comprise the core residues of the superfamily catalytic scaffold. 
Two residues, located within the vicinity of the oxalate ligand, distinguish the 
PA4872 active site from those of other family members with known structure; Tyr212 
positioned on the loop connecting β7 and α7, and His235 located on the loop connecting 
β8 and α8 (Figure 3.3). The His235 Nε is located within hydrogen bonding distance (2.5-
3.0 Å) of the oxalate C(1)O (the same C(1)O that engages in hydrogen bond interaction 
with the Ser50 hydroxyl group; the other C(1)O is coordinated to Mg2+) and possibly 
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within hydrogen bonding distance of the oxalate C(2)O (3.2 -3.8 Å) (the other C(2)O is 





Figure 3.3 - Active site of PA4871. (A) The electron density associated with key active site 
residues. The sigma(a)-weighted 2Fo – Fc map is shown contoured at 2σ level. Atomic colors are 
used: Carbon – green, oxygen – red, nitrogen – blue, Mg2+ - yellow. Oxalate is labeled Oxl (B) 
stereoscopic representation of the active site. Atomic colors are: Carbon – gray, oxygen – red, 
nitrogen – blue, Mg2+ - green.  
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The H235 imidazole tautomer in which both the Nε and Nδ atoms are protonated is 
evidenced by the hydrogen bond network associated with Nδ. Specifically, the His235 Nδ 
functions as a hydrogen bond donor and Ser27 hydroxyl (2.5 – 3.0 Å) as a hydrogen bond 
acceptor (Figure 3.3). In turn, Ser27 hydroxyl serves as a hydrogen bond donor to an 
internal water molecule that donates its hydrogen atom to the backbone carbonyl groups 
of Val28 and Ile46, and accepts a hydrogen bond from the backbone amide group of 
Gly48 (not shown). The conclusion that His235 is charged is consistent with he pH of 
the crystals (6.0). Within the PA4872 sequence family (Figure 3.4), His235 is stringently 
conserved and position 27 is occupied by a serine or a threonine.  The hydrogen bond 
network suggests that the His235-Ser27 pair plays an important structural role in 
maintaining the fold integrity and active site architecture. However, site directed 
mutagenesis studies described below show that His235 does not play a major mechanistic 
role despite its close proximity to the oxalate and by inference to the substrate.  
The Tyr212 hydroxyl group is positioned close to the oxalate ligand but not close 
enough for hydrogen bond interaction. Tyr212 is conserved among the majority of the 
PA4872 sequence family members (Figure 3.4). Although the gating loop is rdered in 
the PA4872 crystal structure, it does not close over the active site. Other examples of an 
“active site-open loop conformation” have been observed in X-ray structures of 
superfamily members that are known to require loop closure for catalytic turnover 
(Huang, Li et al. 1999; Liu, Lu et al. 2004; Liu, Lu et al. 2005; Chen, Han et al. 2006).  
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Figure 3.4 – Structure based sequence alignment of PA4872 close relatives. Invariant active site 
residues that are conserved also in other PEP mutase/isocitrate lyase superfamily members are 
highlighted in blocked green. Other invariant residues are highlighted in blocked gray except for 
the active site His235, Tyr 212 (and the nearby glutamate of the 3-protein subgroup) and Ser27, 
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which are highlighted in blocked red. Secondary structure motifs are shown above the 
sequences. 
 
Loop closure is facilitated by the substrates or substrate analogs that engage i  
favorable electrostatic interaction with one or more loop residues. Because the oxalate 
ligand is not known to interact with the gating loop of other PEP mutase/isocitrate lyase 
superfamily members, the observation that the gating loop does not close over the 
PA4872 active site in the present structure is not substantial evidence that it does not do 
so during catalytic turnover. Yet, a key determinant of loop closure is the interaction 
between a loop lysine and a catalytic site glutamate residue (exemplifi d by Lys120 and 
Glu114 in PEP mutase (7)). PA4872 is unique in that the loop lysine residue is absent. 
For the superfamily members that require a loop closed conformation for catalytic 
turnover, the Glu-Lys interaction serves to pin the gating loop at one side of the active 
site. 
To explore the potential contribution that the gating loop residues might ake to 
the catalytic site we modeled the loop in the active site-closed conformation, using input 
from the structures of other superfamily members as a template (model not shown). 
Although we do not know the accuracy of this model, it does provide an indication that 
the loop does not contribute residues that might function in binding substrate via 
electrostatic interaction or participate in proton transfer (i.e. general acid/base catalysis). 
On the other hand, the model suggests that in the closed conformation, a conserved 
aromatic loop residue, Phe125 (replaced only by Tyr in the sequence family), may restrict
solvent access to the active site.  
A second structural feature of PA4872 that is unique within the superfamily is the 
α-helical C-terminus. Among the α/β-barrel fold structures, the PEP mutase/isocitrate 
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lyase superfamily is distinguished by the use of α/β-barrel 8th helix of one subunit to 
swap with that of the a neighboring subunit (Huang, Li et al. 1999). The α- lical 
segment that follows the 8th helix traverses the active site of the neighboring subunit and 
assists in its desolvation. The unique conformation of the PA4872 C-terminus, in which 
the main chain reverses direction after the α8 helix swapping, creates a channel leading to 
the active site adjacent the C-terminus of β8 (Figure 3.5A). None of the other PEP 
mutase/isocitrate lyase superfamily enzyme structures exhibit such a channel (see for 
comparison, the analogous surface representation of 2-methylisocitrate lyase in Figure 
3.5B, which shows no such channel). The channel exposes the PA4872 active site to 
solvent from the side of the oxalate/pyruvate C(1) carboxylate group. Closure of the 
gating loop, as observed for the loop-closed model, does not close this channel, and 
therefore, we can assume that exposure of this region to solvent occurs during catalytic 
turnover. Solvent exposure occurs with the binary product complex of MOBH bound 
with ketopantoate (11), however this would not occur with the ternary substrate complex 
in which the N5, N10-methylene tetrahydrofolate  “sits on top” of the active sit , thereby 
shielding it from solvent while acting as the hydroxymethyl donor to the ensuing α-
ketoisovalerate anion intermediate (Figure 3.1). The solvent accessibility of the PA4872 






Figure 3.5 – Molecular surfaces in the vicinity of active sites. (A) The channel leading to the 
active site of PA4872 (indicated by an arrow). Mg2+-oxalate, His235 and Tyr212 are shown for 
reference. (B) The surface around the active site of 2-methylisocitrate lyase corresponding to the 
Mg2+-pyruvate where the gating loop is in the open conformation (Liu, Lu et al. 2005).  
3.4.3 Assignment of PA4872 to the enolate-forming branch of the PEP 
mutase/isocitrate lyase superfamily 
 
The reactions catalyzed by the PEP mutase/isocitrate lyasesuperfamily (Figure 
3.1) fall into the two categories represented in Figure 3.6. The reactions atalyzed by PEP 
mutase, phosphonopyruvate  hydrolase and MOBH proceed via a planar α-caboxy 
enolate intermediate (and/or transition state) whereas the reactions catalyzed by isocitrate 
lyase, 2-methylisocitrate lyase, petal death protein and oxaloacetate hydrolase proceed 
with the formation of a α-carboxy alkoxide and aci-carboxylate anion intermediate pair 
(and/or transition state). The conservation of the core residues known to stabilize the α-
oxyanion intermediate, coupled with the absence of polar residues in the region of the 
active site that accommodates the aci-carboxylate anion intermediate formed by the C-C 
bond lyases (Britton, Langridge et al. 2000; Sharma, Sharma et al. 2000; Britton, 
Abeysinghe et al. 2001; Grimm, Evers et al. 2003; Simanshu, Satheshkumar et al. 2003; 
Liu, Lu et al. 2005; Teplyakov, Liu et al. 2005; Han, Joosten et al. 2007) suggested that 
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PA4872 might belong to the α-caboxy enolate intermediate forming branch of the 
superfamily. Activity tests designed to evaluate the ability of the PA4872 catalytic 
scaffold to stabilize an enolate anion intermediate confirmed this hypothesis.  
 
Figure 3.6 –The type of intermediates formed by the mutase/transferase and lyase branches of 
the superfamily. 
 
Blanchard and coworkers carried out solvent deuterium exchange reactions 
monitored by 1H-NMR spectroscopy to demonstrate MOBH catalyzed enolization of α-
ketoisovalerate (Sugantino, Zheng et al. 2003). Although PA4872 lacks the MOBH 
general base (Glu181 in the E. coli enzyme (von Delft, Inoue et al. 2003)) that abstracts 
the C(3)H of the α-ketoisovalerate in the enolization partial reaction (Val188 occupies 
this position in PA4872), PA4872 does conserve the electropositive residues and the 
Mg2+ cofactor that function in stabilization of the α-carboxy enolate anion. Using the 
same 1H-NMR based approach, the rate constants for the enolization (kenol) of pyruvate 
catalyzed by phosphonopyruvate hydrolase and PEP mutase were measured. Like 
PA4872 these enzymes conserve the electropositive residues and the Mg2+ cofactor that 
stabilize the pyruvate enolate intermediate but lack an enzyme residue to function as a 
general base in the enolization of pyruvate. The kenol measured for phosphonopyruvate 
hydrolase is 12 min-1 and that for PEP mutase is 4 min-1. These rate constants are 
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significantly smaller than the kcat values measured for the catalyzed reactions shown in 
Figure 3.1 (105 s-1 (Chen, Han et al. 2006) and 34 s-1 (Kim, Kim et al. 1998), 
respectively) and thus, the turnover rates greatly exceed the enolization rates. In contrast, 
the reported kcat for the Mycobacterium tuberculosis MOBH is 47 min
-1 and the rate 
constant for the enolization of α-ketoisovalerate (kenol) is 752 min-1 (Sugantino, Zheng et 
al. 2003), which greatly exceeds the turnover rate. The difference in kinetic behavior is 
consistent with the fact that MOBH catalyzes the enolization of α-ketoisovalerate as the 
first partial reaction of the overall reaction (Figure 3.1) and thatMOBH possesses a 
general base (Glu181) to assist in the catalysis of the α-k toisovalerate enolization. 
Phosphonopyruvate hydrolase and PEP mutase, on the other hand, do not catalyze 
pyruvate enolization as a partial reaction of the overall reaction, nor do they possesses a 
general base that might facilitate pyruvate enolization. We assume that a water molecule 
functions in base catalysis of the pyruvate enolization. The rate enhancements observed 
with phosphonopyruvate hydrolase and PEP mutase are attributed to the delocalization of 
excess charge from the pyruvate enolate onto the Mg+2 cofactor and the electropositive 
active site residues.  
The kenol determined for the petal death protein is 0.6 min
-1 whereas isocitrate 
lyase and 2-methylisocitrate lyase do not catalyze exchange at a detectable level. These 
three enzymes do not form an enolate anion intermediate (Figure 3.1). Based on these 
results we conclude that the 2 branches of the superfamily are distingu hed by the ability 
vs. inability to catalyze the enolization of α-ketoacids. In this context we interpret the kenol 
= 24 min-1 measured for PA4872 catalyzed pyruvate enolization (Table 3.3) as evidence 
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 To gain information about the structure of the α-carboxy enolate anion 
intermediate formed during PA4872 catalytic turnover of its physiological substrate, the 
kenol for a variety of C(3) substituted pyruvate compounds were measured (Table 3). 
Whereas only α-ketoisovalerate is substrate for the overall reaction catalyzed by MOBH 
(Sugantino, Zheng et al. 2003), this enzyme catalyzes the enolization of pyruvate and 
C(3) substituted pyruvate with the following efficiencies: for the native substrate α-
ketoisovalerate kenol = 752 min
-1; for α-keto--methyl-valerate kenol = 482 min-1; for α-
ketobutyrate kenol = 354 min
-1; for α-ketovalerate kenol = 229 min-1; for pyruvate kenol = 
129 min-1; and for α-ketoisocaproate kenol = 19 min-1. In contrast, PA4872 is only 
significantly active with the linear α-ketoacids for which the order of reactivity is α-
Table 3.3. The rate constant for enolization (kenol) determined from the rate of 
PA4872-catalyzed deuterium exchange from D2O solvent with the C(3)H of 2-
ketoacids  
a The rate constant for the PA4872 H235Q mutant. 
b The rate constant for the PA4872 H235A mutant. 
 48
ketovalerate > α-ketobutyrate > pyruvate (Table 3.3). This result suggested that the native 
substrate is a small linear α-ketoacid. 
3.4.4 PA4872 chemical function determination 
  
The PA4872 active site provides space in a hydrophobic pocket lined by Met208, 
Val210 and Val232, for a small C(3) substituent such as a methyl or ethyl group. 
Adjacent to the Tyr212, there is also space for a second C(3) substituent oriented towards 
the active site exit at the C-terminus edge of the α/β barrel, albeit with slight adjustment 
of the Tyr212 side chain conformation. This suggested the possibility that PA4872 
catalyzes a β-elimination reaction in an α-ketoacid substrate. The obvious candidate for 
such a reaction is oxaloacetate. The PA4872 active site, modeled with oxaloacetate is 
shown in Figure 3.7 along with models built with 3-methyloxaloacetate and 3-
ethyloxaloacetate as the ligands. All three models conserve the lectrostatic interactions 
with the core residues that stabilize the pyruvate enolate while the carboxylate group is 
confined to a position above the plane of the developing pyruvate enolate intermediate, in 




Figure 3.7 – The active site cavity (shown as a cage) with docked potential substrates shown as 
stick models with the atomic colors  green – carbon, red – oxygen. The Mg2+ is depicted as a 
magenta sphere. 
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The addition of PA4872 to a buffered solution of oxaloacetate and Mg2+ was 
accompanied by rapid bubble formation (viz. CO2). 
13C-NMR analysis of the solution 
confirmed that the oxaloacetate had been quantitatively converted to pyruvate and 
bicarbonate. The steady state rate constants for this reaction were measured using two 
different assay methods. The first monitors the disappearance of oxaloacetate 
(absorbance decrease at 255 nm) and the second monitors the formation of pyruvate via 
coupled reaction with lactate dehydrogenase and NADH (absorbance decrease at 340 
nm). The results are presented in Table 3.4. 
Table 3.4. Steady-state kinetic constants for PA4872 catalyzed decarboxylation of 
oxaloacetate and 3-methyloxaloacetate 
 
 Substrate                         Assay       kcat (s
-1)             Km (mM)            kcat/Km (M
-1s-1) 
oxaloacetate                                direct           7500 ± 200        2.2 ± 0.1                3 × 106 
oxaloacetate                               coupled        7200 ± 400        1.3 ± 0.2                6 × 106 
3-methyl-oxaloacetate       coupled          250 ± 10          0.63 ± 0.08            4 × 105 
3-methyl-oxaloacetate a  1H-NMR            800                  --------               -------- 
a The reaction mixture in this assay initially contained  10 mM 3-methyloxaloacetate, 5 mM 
MgCl2, 6 nM PA4872, 50 mM KH2PO4 (pH 7.0, 20 °C), and 1 mM sodium acetate (as the 
internal standard). The 1H-NMR of 3-methyloxaloacetate measured under the reaction 
conditions defines the relative ratio of enol:ketone:gem diol as  1.7: 0.8: 0.8.  The rate of 
decarboxylation of 3-methyloxaloacetate in buffer is 0.052 mM/min, the rate in MgCl2-
containing buffer is 0.078 mM/min whereas the rate measured in the presence of the 6 nM 
PA4872 is 0.38 mM/min. 
 
 Owing to the fact that oxaloacetate is a slow substrate for lactate dehydrogenase 
(hence a background rate must be subtracted) the direct assay is likely to be the more 
accurate measurement. The kcat = 7500 s
-1 is 2-3 orders of magnitude larger than the kcat 
of PEP mutase (kcat = 34 s
-1 for the enzyme from Mytilus edulis (Kim, Kim et al. 1998)), 
phosphonopyruvate hydrolase (kcat = 105 s
-1 for the enzyme from Variovorax sp. Pal2 
(Chen, Han et al. 2006)), oxaloacetate hydrolase (kcat = 10 s
-1 for the enzyme from 
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Botrytis cinerea (Han, Joosten et al. 2007)), isocitrate lyase (kcat = 100 s
-1 for the enzyme 
from E. coli (Liu, Lu et al. 2005)), 2-methylisocitrate lyase (kcat = 19 s
-1 for the enzyme 
from E. coli (Liu, Lu et al. 2005)), and petal death protein (kcat = 8 s
-1 for the best 
substrate (Lu, Feng et al. 2005)) in reaction with their physiological substrates. The kcat is 
4 orders of magnitude larger than that of the MOBH (kcat= 0.8 s
-1).  
Knowledge of the kcat for PA4872 catalysis of its physiological reaction allows us 
to contrast the efficiency by which the pyruvate enolate is formed by decarboxylation of 
oxaloacetate to the efficiency at which the enzyme catalyzes th  enolization of bound 
pyruvate; at kcat = 7500 s
-1 vs. kenol = 0.4 s
-1, the trend is the same as PEP mutase and 
phosphonopyruvate hydrolase, and the reverse of MOBH. Although the His235 N is 
located near the C(3) of the modeled oxaloacetate it does not makea significant 
contribution to catalysis of α-ketoacid enolization. Specifically, kenol values measured for 
H235A and H235Q PA4872 with the best enolization substrate (α-k tovalerate) are only 
3-fold smaller than that of wild-type PA4872 (Table 3.3).  
The models of PA4872 bound with 3-methyl- and 3-ethyloxaloacetate (Figure 
3.7) suggested that these compounds might also be good substrates for PA4872 
decarboxylation. 3-methyloxaloacetate is a metabolite formed from L-threo-3-
methylaspartate within the C-5 branched dibasic acid metabolic pathway 
(http://www.genome.ad.jp/kegg/pathway.html; (Kanehisa, Goto et al. 2006)) and thus a 
potential physiological substrate for PA4872. 3-Methyloxaloacetate was prepared by 
chemical synthesis (see Supporting Information) and the rate of PA4872 decarboxylation 
was monitored by 1H-NMR to define a turnover rate of 790 s-1 at 10 mM 3-
methyloxaloacetate (Table 3.4). The steady-state kinetic constants were measured using 
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the LDH/NADH coupled assay for formation of α-ketobutyrate defining kcat = 250 ± 10 s-
1,  Km = 0.63 ± 0.08 mM and kcat/Km = 4 × 10
5 M-1 s-1. Although the kcat/Km value is an 
order of magnitude smaller than that measured for oxaloacetate, it is still large enough to 
support the possible physiological relevance of this reaction. Whereas, the C(3)CH3 
substituent increased the rate of the enolization of the α-k toacid  2-fold (α-ketovalerate 
kenol = 56 min
-1 vs. pyruvate kenol = 24 min
-1) it decreased the rate of decarboxylation in 
the corresponding diacid 3-methyloxaloacetate relative to oxaloacetate by ~20-fold. Thus, 
the PA4872 catalyzed decarboxylation reaction is hindered by the C(3)CH3 substituent 
and based on this observation we hypothesize that the PA4872 evolved to function in the 
decarboxylation of the main stream metabolite oxaloacetate  rather than the 
decarboxylation of the more obscure metabolite 3-methyloxaloactate.    
3.4.5 PA4872 catalytic proficiency 
 
The rate of oxaloacetate decarboxylation in aqueous solution was investigat d 
earlier using 3-methyloxaloacetate in place oxaloacetate so that the reaction can be 
monitored by 1H-NMR. The rate measured at pH 4.6 and 31oC was 7.8 x10-5 s-1 (Kubala 
and Martell 1981). The rate does not increase at higher pH nor does the presence of Mg+2 
has a large impact on the reaction (~2-fold increase). Thus, the approximate value for 
kcatalyzed/ksolution is 10
8.  
The steady state kinetic constants measured for decarboxylation of oxal acetate 
catalyzed by PEP mutase are kcat =0.269 ± 0.004 s
-1 and Km = 0.22 ± 0.01 mM (kcat/Km = 
1.2 × 103 M-1 s-1). The values measured for phosphonopyruvate hydrolase are kcat = 1.04 
± 0.02 s-1 and Km = 1.6 ± 0.1 mM (kcat/Km = 6.5 × 10
2 M-1 s-1). Our “control enzyme” 2-
methylisocitrate lyase did not catalyze oxaloacetate decarboxylation at a detectable rate 
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(kcat < 1 x 10
-3 s-1). Thus, the ability of the members of the pyruvate enolate intermediate 
forming branch of the PEP mutase/isocitrate lyase superfamily to stabilize the pyruvate 
enolate anion (Figure 3.6) is sufficient to confer a weak decarboxylase activity on them. 
The proficiency of the PA4872 (kcatalyzed/ksolution ~ 10
8) is substantially greater than that of 
PEP mutase (kcatalyzed/ksolution ~ 10
3) and phosphonopyruvate hydrolase (kcatalyzed/ksolution ~ 
104). Hence, PA4872 diverged in function through optimization of the an active site 
environment to facilitate decarboxylation. 
3.4.6 PA4872 Substrate Recognition  
 
The binding constants for substrate and intermediate analogs were det mined by 
measuring the competitive (vs. oxaloacetate) inhibition constant (Ki) for these 
compounds. The pyruvate enolate analog used in the X-ray structure determination, 
oxalate, was found to have a Ki = 43 µM (Table 3.5). This value is comparable to the Ki = 
25 µM measured for PEP mutase (Liu, Lu et al. 2002). In contrast, phosphonopyruvate, 
which binds very tightly to PEP mutase (Km = 1 µM and Ki for sulfopyruvate = 40 µM) 
(Kim, Kim et al. 1998; Liu, Lu et al. 2002), binds very poorly to PA4872 (Ki = 3 mM). 
Thus, the two enzymes share tight binding to the pyruvate enolate anlog but diverge in 
substrate recognition. Oxalate is also the product of oxaloacetate hydrolase and petal 
death protein catalyzed oxaloacetate cleavage. The Ki values measured for these two 







Table 3.5. The competitive inhibition constant determined for PA4872 catalyzed 
oxaloacetate decarboxylation. a The inhibition constant was measured for the 
PA4872 Y212F mutant rather than the wild type PA4872. 
 
 
 3,3-Difluoroxaloacetate, which differs from oxaloacetate by replac ment of the 
C(3) hydrogens with fluorine atoms, is not a substrate for PA4872 decarboxylation. Nor 
is it a substrate for oxaloacetate hydrolase catalyzed hydrolytic cleavage (Han, Joosten et 
al. 2007). Whereas oxaloacetate exists predominantly in the C(2) keto form (Lu, Feng et 
al. 2005), the 3,3-difluoroxaloacetate exists predominantly in the C(2) gem diol (hydrate) 
form (Han, Joosten et al. 2007). Oxaloacetate hydrolase catalyzes C(2)-C(3) bond 
cleavage in the oxaloacetate gem diol. The tight binding of 3,3-difluoroxaloacetate (Ki = 
68 nM, (Han, Joosten et al. 2007)) suggests that the enzyme active site is specialized in 
recruiting or generating the gem diol form of oxaloacetate. It is not clear why the fluorine 
atoms at C(3) impair the C(2)-C(3) cleavage step. PA4872 binds 3,3-difluoroxaloacetate 
7500-fold less tightly than does oxaloacetate hydrolase at Ki = 450 M and is unable to 
decarboxylate this substrate analog. The comparatively higher stability of the 3,3-
difluoroxaloacetate to decarboxylation in solution and in the presence of PA4872 may be 
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due to the predominance of the gem diol and/or another inherent property of the keto 
form. The Ki values of α-ketovalerate (6.7 mM) and pyruvate (7.2 mM) were measured to 
determine whether the C(3) ethyl substituent enhances binding affinity, which it does not 
(Table 3.5). Lastly, we synthesized acetopyruvate (see Supporting Information) to test as 
an oxaloacetate analog. The Ki = 1 mM indicates a ~7-fold tighter binding than observed 
for pyruvate. 
3.4.7   PA4872 Catalytic Mechanism 
 
Shown in Figure 3.8 are the key interactions of oxaloacetate modeled in the 
PA4872 active site. These are analogous to the set of interactions of the 
phosphonopyruvate substrate in the actives sites of PEP mutase and phosphonopyruvate 
hydrolase, which share with PA4827 the capacity to catalyze oxaloacetate 
decarboxylation (albeit at a much reduced rate). The modest oxaloacetate decarboxylase 
activity of PEP mutase and phosphonopyruvate hydrolase is evidence that these 
interactions are applicable to oxaloacetate binding and decarboxylati n nd that the 
difference in catalytic efficiency originates in difference in the active site environments. 
Not shown in Figure 3.8 are the two polar residues of the PA4872 active site with the 
greatest potential to facilitate the decarboxylation are His235 and Tyr212 (Figure 3.3), 
conserved residues in the PA4872 sequence family (Figure 3.4) that are bsent in PEP 
mutase and phosphonopyruvate hydrolase. At first glance one might envision hydrogen 
bond interaction between the Tyr212 hydroxyl group and the oxaloacetate C(3)COO- and 
a role for the His235 in general acid catalysis. Further analysis, however did not support 
either catalytic role because replacements of these two residues did not impact enzyme 
efficiency significantly (Table 3.6). 
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Figure 3.8 – Proposed catalytic mechanism of PA4872 and comparison with the catalytic 
machinery of the malic enzyme oxaloacetate decarboxylase. 
 
Perhaps noteworthy is the 25-fold reduction in the Km value of the Y212F mutant, 
which suggests that the Tyr212 hydroxyl group impairs substrate binding yet at the same 
time it facilitates catalysis (the kcat of Y212F PA4872 is reduced by 23-fold). This 
conjecture is supported by the observation that the Ki values measured for acetopyruvate 
(aceto group in place of the oxaloacetate C(3) carboxylate group) and α-ketovalarate 
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(ethyl group in place of the oxaloacetate C(3) carboxylate group) are 2-fold smaller than 
those measured for the wild-type enzyme (Table 3.5).  
Table 3.6. Steady-state kinetic constants for mutant PA4872 catalyzed decarboxylation of 
oxaloacetate.a 
                           kcat (s
-1)                   Km (µM)                           kcat/Km (M
-1s-1) 
WT                    7500 ± 200                 2200 ± 100                       3.4 × 106 
Y212F               323 ± 6                       87 ± 4                                3.7 × 106 
H235A               510 ± 7                      1020 ± 50                           5.0 × 105 
H235Q              2580 ± 90                   2500 ± 200                         1.0 × 106 
a 0.25 mL reaction mixture contained 50 mM K+Hepes (pH 7.5, 25 °C), 5 mM MgCl2, 0.5-10 
Km of oxaloacetate. Reactions were monitored at 255 nm. 
 
Relevant to the catalytic mechanism, the pH rate profile data (Figure 3.9) shows 
that there is no change in the kcat value over the pH 5-10 range and there is not sufficient 
variation in the kcat/Km to assign to the ionization of an essential residue. This rules out 
that a protonated His235 serves as the general acid in the decarboxyl tion reaction. 
Otherwise we would anticipate a drop in catalytic efficiency above pH 6.5. Moreover, the 
kcat and kcat/Km values determined for H235A and H235A catalysis of oxaloacetate 
decarboxylation are less than an order of magnitude smaller than the kcat and kcat/Km value 
measured for wild-type PA4872. The stringent conservation of the histidine residue 
among the PA4872 sequence family members is attributed to its structural role (described 
in a previous section) rather than to a catalytic role. Because Tyr212 and His235 do not 
































Figure 3.9 – pH profile of PA4872. The buffers used in various pH ranges are listed in the 
Methods section 
 
The origin of the greater rate enhancement observed with PA4872 vs. the PEP 
mutase and phosphonopyruvate hydrolase is currently unknown but may arise from two 
unique structural features. The first is a sterically restricted hydrophobic region of the 
active site which is able to confine the C(3)COO- in an orientation optimal for the 
dissociation of CO2 (Figure 3.7).  If the gating loop closes, the desolvation of the 
C(3)COO- into a nonpolar region of the active site is also expected to contribute to 
ground state destabilization that is relieved as the charge is tran ferred to the C(3) upon 
CO2 dissociation. The second important feature of the PA4872 active site is th solvent 
access to C(3) provided by the channel (Figure 3.6), which is unique to PA4872. A water 
molecule that approaches C(3) from that direction may serve as the acid that protonates 
the pyruvate enolate. 
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There are several other enzyme superfamilies from which an oxaloacetate 
decarboxylase has emerged. Pyruvate kinase possess an intrinsic oxaloacetate 
decarboxylase activity owing to its ability to stabilize a pyruvate enolate intermediate, but 
oxaloacetate is not considered its physiological substrate (Creighton and Rose 1976; 
Jursinic and Robinson 1978). The malic enzyme catalyzes oxaloacetate d carboxylation 
as the second partial reaction in the conversion of malate to CO2 plus pyruvate with the 
reduction of NAD to NADH (Park, Harris et al. 1986). CitM within the malic enzyme 
family has evolved to function in a specialized citrate degradation pathway in a small 
group of Gram- positive bacteria  (Sender, Martin et al. 2004). The CitM cannot convert 
malate to oxaloacetate but it does decarboxylate oxaloacetate at n efficiency of kcat = 20 
s-1 and Km = 0.5 mM using the same catalytic residues of the malic enzyme. The catalytic 
residues of CitM and the malic enzyme (Chang and Tong 2003) are depicted in Figure 
3.8 along with two possible pathways for the catalyzed decarboxylation. As with 
PA4872, a Mg+2 cofactor is used along with several electropositive active residu  to 
bind the α-keto acid moiety. There are however distinct differences in catalytic 
mechanism. Firstly, the carboxylate is oriented for the dissociation by binding to an 
asparagine side chain and an internal water molecule. Secondly, a tyrosine residue is 
positioned close to the C(3) so that it might function as the acid catalyst (pathway a). 
Alternatively, the Lys residue that engages in hydrogen bond formation with the substrate 
C(2)=O may transfer its proton as the reaction proceeds (pathway b). Despite its 
seemingly more sophisticated catalytic site, the catalytic efficiency of CitM is 
significantly lower than that of PA4872. 
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A third known “dedicated” oxaloacetate decarboxylase is the oxaloacetate 
decarboxylase Na+ pump present in a wide range of bacterial species. This membrane 
protein system catalyzes the transfer of the C(3) carboxyl group of oxaloacetate to a 
biotin prosthetic group and the decarboxylation of the carboxybiotin, coupled to Na+ 
translocation. The recent crystal structure of the enzyme shows that the Zn2+-dependent 
oxaloacetate decarboxylase domain adopts an α/β barrel fold, but otherwise the catalytic 
mechanism is entirely different than that of PA4872 (Studer, Dahinden et al. 2007); a 
catalytic lysine residue serves as the acceptor of the CO2 from oxaloacetate and transfers 
it to biotin, which induces the sodium translocation.  
A fourth dedicated oxaloacetate decarboxylase from Pseudomonas species has 
been characterized. This large (~600 amino acids) 3-domain decarboxylase is found in a 
wide range of Gram-negative bacteria, including the same specie  of bacteria that 
produce the PA4872 family members. Although the structure of this enzyme has not been 
determined, the stereochemistry of the protonation with inversion at C(3) has been 
reported (Piccirilli, Rozzell et al. 1987) as well as the results from an in depth 
examination of transition state structure, metal cofactor activation and pH effects 
(Waldrop, Braxton et al. 1994).  
3.4.8   PA4872-like species distribution and biological function 
 
PA4872 orthologs are found in all deposited Pseudomonad genomes (genus of γ-
proteobacteria) and in only a few other Gram-negative bacteria. The most distinguishing 
sequence features in this group of enzymes is the invariant His235-Ser27 (or Thr) pair, 
the lack of the conserved lysine that regulates the closure of the ga ing active site loop, 
and the very different sequence of the gating loop compared with other enzymes in the 
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PEP mutase/isocitrate lyase superfamily (Figure 3.4). Two of the Pseudomonad species 
each have a strain that contain two copies of the gene (paralogs), well separated within 
the genome. One paralog shares high sequence identity with PA4872 (>70%) while the 
other shares 50-60% identity. The identity level of both paralogs within a genome is 
sufficiently high to indicate the same chemical function although their substrate 
specificity may vary. Within the Pseudomonad group the sequence identity be ween 
PA4872 and the closest homologues is 70-99 %. Outside of the Pseudomonad group it is 
in the 70-80% range for Chromohalobacter salexigens, Reinekea sp. MED297 and 
Marinomonas sp. MWYL1, but drops to the 50-52% for Rhodopseudomonas palustris 
strains (genus of α-proteobacteria), 44-47% for Bradyrhizobium strains (α-division) and 
down to 40% for the Burkholderia xenovorans (β- division). Importantly, B. xenovorans 
is the only species of the many Burkholderia species whose genome sequ nces have been 
determined that contains a PA4872 ortholog. This was confirmed by a BLAST search of 
the Burkholderiaceae group using the B. xenovorans as query that showed only lyase 
sequences (clearly identified by the active site gating loop sequence) at 30-36% identity. 
The second PA4872-like copy is found in Pseudomonas fluorescens PfO-1 and in 
Pseudomonas putida W619 but in no other reported species. This paralog is expected to 
have identical substrate specificity in both organisms because the sequence identity 
between the two is 84%. Based on the species distribution it is evident that PA4872 
performs a specialized metabolic function in a select group of Gram-negative bacteria 
restricted to all Pseudomonads of defined genome sequence (γ-proteobacteria), a few 
among the many α-proteobacteria, and a single, environmental, β-proteobacteria. Because 
oxaloacetate and pyruvate are key intermediary metabolites that link numerous pathways 
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and because carbonate is used as a precursor for biotin mediated caboxylation reactions, 
the oxaloacetate decarboxylase could have many potential metabolic uses. Indeed, the 
genome context analysis described below lead us to the conclusion that the 
Pseudomonads, which exhibit great metabolic diversity, may utilize the oxaloacetate in a 
variety of processes that require the supply of pyruvate or bicarbonate.     
The genome contexts of the PA4872 and its close relatives were examin d to 
obtain clues about the biological function, underscoring the variety of contexts in which 
they are found. Only in the R. palustris strains and the B. japonicum UDSA110 are the 
oxaloacetate decarboxylase encoding genes organized in an operon. In R. palustris 
strains, the flanking genes (separated by 1-6 nucleotides) are homologs of acyl 
phosphatase (hydrolysis of acylphosphate metabolites to the corresponding carboxylic 
acid and orthophosphate) and the α subunit of acyl-CoA carboxylase (phosphorylation of 
carbonate with ATP to form carboxyphosphate, followed by the transfer of CO2 from the 
carboxyphosphate to biotin). We speculate that in these two bacterial species, the 
bicarbonate produced by the oxaloacetate decarboxylase is fixed in the cell by reaction 
with the biotin carboxylase subunit of the acyl-CoA carboxylase. The connection wi h the 
acyl phosphatase is not clear. However we note that in other bacteria (for example 
Nitrobacter hamburgensis X14) that do not contain the oxaloacetate decarboxylase 
encoding gene, the genes encoding the acyl phosphatase and the biotin carboxylase are 
co-transcribed.  
The biotin carboxylase, oxaloacetate decarboxylase and acyl phosphatase 
homologues are also adjacent to one another in the genome of B. japonicum UDSA110. 
However, only the oxaloacetate decarboxylase and acyl phosphatase genes are clearly co-
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transcribed (3 nucleotide separation). The biotin carboxylase gene is separated from the 
oxaloacetate decarboxylase by 149 nucleotides. Perhaps coincidental but nonetheless 
intriguing, the citrate lyase gene cluster is located in the neighborhood of the biotin 
carboxylase, oxaloacetate decarboxylase and acyl phosphatase genes within the R. 
palustris BisB18 genome. The citrate lyase converts citrate to oxaloacetate.   
The genome contexts of other PA4872 sequence family members are not as 
informative; the genes are not located on operons and the neighboring genes tend to be 
different. Yet, it is intriguing that Pseudomonas stutzeri A1501, and Pseudomonas 
mendocina ymp, and the two annotated P. aeruginosa genomes, PAO1 and PA7, position 
the oxaloacetate decarboxylase gene in the same neighborhood as the urease op ron. 
Urease, which plays an important role in nitrogen acquisition and recycling requires CO2 
for the synthesis of its nickel metallo center (Park and Hausinger 1995). Next to the 
urease operon is an amino acid transporter. It is possible that the close arrangement of the 
amino acid transporter, urease and oxaloacetate decarboxylase genes is not coincidental.  
The P. fluorescens Pf-5 oxaloacetate decarboxylase gene is included among the 
genes encoding acetylornithine aminotransferase (of the urea cycle) and the enzymes of 
the nicotinamide metabolic pathway. P  fluorescens PfO-1 has two PA4872 homologs; 
the closest to PA4872 in sequence (78%) is clustered with arginine N-succinyltransferase, 
N-formylglutamate amidohydrolase, glutamine synthetase and an amino cid transporter. 
The respective gene clusters are suggestive of amino acid transport and recycling. The 
pyruvate generated by the oxaloacetate decarboxylase may serve as a NH3 acceptor in the 
synthesis of alanine. The genomes of the Ps udomonas syringae strains include the gene 
encoding oxaloacetate decarboxylase as neighbor to the gene encoding is propyl malate 
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synthase (leucine biosynthesis) and the genes encoding an amidase and an 
aminotransferase.  
A common denominator in each of the gene contexts described above is the 
metabolism of amino acids, in which pyruvate might participate. The oxaloacetate 
decarboxylase gene of P. fluorescens PfO-1 (the second homolog having 55% identity 
with PA4872) along with that of the Burholderia xenovans and P. putida F1 are clustered 
with genes that form a carboxylate transporter and degradation pathway. The genome 
context of the oxaloacetate decarboxylase gene of Pseudomonas entomophila has no 
relationship to any of the genes listed above, and its neighboring genes share no common 
function with one another except that there are several genes related to antibiotics 
resistance. 
Based on essential gene analysis in P. aeruginosa PAO1 using transposon 
insertion technology, PA4872 is not required for survival (Jacobs, Alwood et al. 2003). 
Taken together, the currently available information suggests that the oxaloacetate 
decarboxylase gene was acquired by all Pseudomonads and by a few other organisms as 
an auxiliary enzyme that helps maintain the supply of two key metabolites f r a variety of 
cellular processes. 
Accession numbers 
The coordinates and structure factors have been deposited in the Protein Data 
Bank (entry code 3B8I). 
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Chapter 4   Structure and Function of 2,3-Dimethylmalate 
Lyase, a PEP Mutase/Isocitrate Lyase Superfamily Member 
4.1   Abstract 
The Aspergillus niger genome contains four genes that encode proteins exhibiting 
greater than 30% amino acid sequence identity to the confirmed oxaloacetate acetyl 
hydrolase (OAH), an enzyme that belongs to the phosphoenolpyruvate mutase 
(PEPM)/isocitrate lyase (ICL) superfamily. Previous studies have shown that a mutant A. 
niger strain lacking the OAH gene does not produce oxalate. To identify the function of 
the protein sharing the highest amino acid sequence identity with the OAH (An07g08390, 
Swiss-Prot entry Q2L887, 57% identity), we produced the protein in Escherichia coli and 
purified it for structural and functional studies. A focused substrate screen was used to 
determine the catalytic function of An07g08390 as (2R, 3S)-dimethylmalate lyase 
(DMML): kcat = 19.2 s
-1 and Km = 220 µM. DMML also possesses significant OAH 
activity (kcat = 0.5 s
-1 and Km = 220 µM). DNA array analysis showed that unlike the A. 
niger oah gene, the DMML encoding gene is subject to catabolite repression. DMML is a 
key enzyme in bacterial nicotinate catabolism, catalyzing the last of nine enzymatic steps. 
This pathway does not have a known fungal counterpart.   BLAST analysis of the A. 
niger genome for the presence of a similar pathway revealed the pres nce of homologs to 
only some of the pathway enzymes. This and the finding that A. niger does not thrive on 
nicotinamide as a sole carbon source suggests that the fungal DMML functions in a 
presently unknown metabolic pathway. The crystal structure of A. niger DMML (in 
complex with Mg2+ and in complex with Mg2+ and a substrate analog: the gem-diol of 
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3,3-difluoro-oxaloacetate) was determined for the purpose of identifying structural 
determinants of substrate recognition and catalysis. Structure guid d site directed mutants 
were prepared and evaluated to test the contributions made by key activ  site residues. In 
this paper we report the results in the broader context of the lyase branch of the 
PEPM/ICL superfamily to provide insight into the evolution of functional diversity. 
4.2   Introduction 
The goal of our work is to discover new chemistries catalyzed by the ICL/PEPM 
superfamily and to determine the unique structural features of the enzyme active sites that 
diversify the catalytic function of the superfamily active site scaffold.  A striking feature 
of the PEPM/ICL superfamily is the absence of clear sequence boundaries between 
functionally different enzymes. The high sequence homology between paired enzymes 
even from different chemical branches (for example 40% identity between carboxyPEPM 
and the PDP, which is a (2R,3S)-2-alkyl-3-methylmalate lyase) has resulted in an 
unusually high level of miss-annotation of biochemical function in the public sequence 
data banks. The present study was carried out as part of a larger effort that is aimed at 
identifying mechanism based sequence markers for use in accurate f nc ion assignment. 
Herein we report on the structure-function study of the unknown protein An07g08390 
ORF (GeneBank accession number DQ349131, Swiss-Prot entry Q2L887) from the 
oxalic acid producing fungus Aspergillus niger. At the outset of this work the A. niger 
genome was known to encode the PEPM/ICL superfamily OAH, which cleaves 
oxaloacetate to oxalate and acetate. A mutant strain (NW228) lacking the gene does not 
produce oxalic acid (van den Hombergh, van de Vondervoort et al. 1995; Ruijter, van de 
Vondervoort et al. 1999). Yet, the A. niger genome (Pel, de Winde et al. 2007) contains 
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four additional OAH homologs, one of which (An07g08390) shares 57% sequence 
identity with A. niger OAH. Although such a high level of sequence identity usually 
indicates identical function, the phenotype of the gene knockout strain suggests 
otherwise. Herein, we examine the catalytic function of An07g08390 as defined by in 
vitro substrate screening; the biological function as defined by bioinformatics, gene 
knockout mutants and DNA array analysis; and the structural basis for the evolution of 
this novel enzyme within the PEPM/ICL superfamily. 
4.3   Materials and methods 
4.3.1   Chemicals and General methods  
Except where indicated, all chemicals were purchased from Sigma-Aldrich. 
Oxaloacetic acid, (R)-malic acid, (S)-malic acid, (2R)-methylmalic acid, (2S)-
methylmalic acid, (2R,3S)-isocitric acid were purchased from Sigma-Aldrich. (2R,3S)-
2,3-dimethylmalic acid, (2R,3S)-2-ethyl-3-methylmalic acid, (2R,3S)-2-propyl-3-
methylmalic acid, (2R,3S & 2S,3R)-2-methylisocitrate (threo isomers) were prepared 
according to published procedures (Lu, Feng et al. 2005). (3S -Isopropylmalate and 3-
butylmalate were a gift from Dr. Steve Clarke, UCLA and CPEP was a gift from Dr. John 
Gerlt (University of Illinois). Custom-synthesized PCR primers were obtained from 
Invitrogen as were the restriction enzymes, the pfu polymerase, and the T4 DNA lyase. 
DNA sequencing analysis was carried by the DNA Sequencing Facility of the University 
of New Mexico. SDS-PAGE was performed with gels prepared from12% acrylamide gel 
with a 4% stacking gel (37.5:1 acrylamide:biacryamide ratio) (Bio-Rad). Protein 
concentrations were determined using the Bradford method. 
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4.3.2   Cloning, expression and gene product purification 
The DMML-encoding An07g08390 gene from the A. niger wild type strain N400 
(CBS120.49) was amplified by PCR using the forward primer 
ATGCCTATGGTAACTGCAGCT and the reverse primer 
CTACTTCAGGTCCACCCCTCC in conjunction with the Pfu DNA polymerase kit from 
Fermentas. The PCR product was cloned in vector pGEM®-T Easy (Promega) and 
sequenced. The P240T mutant was made by using the Quikchange Site-Direct d 
Mutagenesis method and the mutation was verified by sequencing. The nucl otide 
sequence of the N400 strain has been deposited in the public databases under accession 
no DQ349131. The DMML-P240T encoding gene was amplified by using a PCR-based 
strategy (Erlick 1992 ) with the DMML-P240T-pGEM®-T easy vector clone serving as 
the template. The Ile142 codon “ATC” was mutated into “ATT” to remove the included 
BamH I restriction site. The clone containing the mutated DMML-P240T gene was 
digested with BamH I and Ned I, and the gene ligated to the pET-3c vector (Novagen) cut 
with BamH I and Ned I. The recombinant plasmid, DMML-P240T-pET3c, was used to 
transform competent E. coli BL21(DE3) cells (Novagen). DMML wild type was 
subcloned using Quikchange site-directed mutagenesis method using DMML-P240T-
pET3c as the template. The transformed cells BL21 (DE3) weregrown at 20 °C with 
mild agitation (180 rpm) in Luria broth containing carbenicillin (50 µg/mL). After 14 h of 
cell growth (OD600nm ~ 0.7), induction was initiated with 0.4 mM IPTG (RPI Corp.). The 
culture was incubated for 10 h at 20 °C under conditions of mild mixing (180 rpm). The 
cells were harvested by centrifugation (6500 RPM; 7,808g) for 15 min at 4 °C in a yield 
of 3.3 g/ L of culture media. The cell pellet (40 g) was suspended in 400 ml of ice-cold 
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lysis buffer (50 mM K+ HEPES (pH 7.5), 1 mM EDTA, 1 mM benzamide hydrochloride, 
0.05 mg/ml trypsin inhibitor, 1 mM 1, 10-phenanthroline, 0.1 mM PMSF and 5 mM 
DTT). The suspension was passed through a French Press at 1200 PSI, and then 
centrifuged at 4 °C for 1 h at 20000 RPM (48,384g). The supernatant was loaded onto a 
4.5 x 40 cm Q-Sepharose column equilibrated with 1 L Buffer A (50 mM triethanolamine 
(pH 7.5), 5 mM MgCl2, 1 mM DTT). The column was washed with 1 L of Buffer A, and 
then eluted with a 2 L linear gradient of 0 to 0.7 M KCl in Buffer A. The column 
fractions were analyzed by measuring the absorbance at 280 nm and by carrying out 
SDS-PAGE analysis. The enzyme eluted at 0.4 M KCl. Ammonium sulfate was added to 
the combined fractions to generate 25 % saturation. The resulting solution was loaded 
onto a 3 x 30 cm Butyl Sepharose column equilibrated at 4 °C with 25 % ammonium 
sulfate in 450 mL of Buffer A.  The column was washed with 450 mL of 25 % 
ammonium sulfate in Buffer A and then eluted with a 1 L linear gr dient of 25 % to 0 % 
ammonium sulfate in Buffer A. The column fractions were analyzed by measuring the 
absorbance at 280 nm and by carrying out SDS-PAGE analysis. The enzyme eluted at 17 
% ammonium sulfate. Ammonium sulfate was added to the combined fractions to 
generate 25 % saturation. The resulting solution was loaded onto a 3 x 30 cm Phenyl 
Sepharose column equilibrated at 4 °C with 25 % ammonium sulfate in 450 mL of Buffer 
A.  The column was washed with 450 mL of 25 % ammonium sulfate in Buffer A and 
then eluted with a 1 L linear gradient of 25 % to 0 % ammonium sulfate in Buffer A. The 
column fractions were analyzed by measuring the absorbance at 280 nm and by carrying 
out SDS-PAGE analysis. The enzyme eluted at 0 % ammonium sulfate. The desired 
fractions were combined, concentrated at 4 °C with an Amicon concentrator and then 
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dialyzed against Buffer A. The resulting sample was concentrated using a MACROSEP 
10K OMEGA for storage at –80 °C. The protein sample was shown to be homogeneous 
by SDS-PAGE analysis. Yield: 20 mg protein/g wet cell. 
4.3.3   Preparation of DMML site-directed mutants 
The C124S, C124A, D59S, D59A and Y44F mutant genes were prepared using a 
PCR-based strategy (Erlick 1992 ) with pfu polymerase, commercial primers and the 
wild-type-pET3c clone as the template. Mutant protein purificatons followed the same 
protocol as described for the wild-type recombinant enzyme. Protein homogeneity was 
confirmed by SDS-PAGE analysis.  
4.3.4   Preparation of His6-tagged wild-type and P240S mutant enzymes  
Owing to the insolubility of the P240S mutant the His6-tagged protein was 
prepared. The His6-tagged wild type enzyme was also prepared to serve as a control. The 
His6-tagged proteins were prepared by ligating the Nde I and BamH I PCR products to 
the (His6-tag encoding) pET14b vector linearized with Nde I and BamH I.  The 
recombinant plasmids were purified and used to transform E coli. BL21(DE3) competent 
cells (Novagen). The transformed cells were grown at 25 °C with mild agitation (180 
rpm) in Luria broth (LB) containing 50 µg/mL of carbenicillin. After 11 h of cell growth 
(OD600nm ~ 0.8), induction was initiated with 0.4 mM IPTG. The culture was incubated 
for 11 h at 20 °C under conditions of mild mixing (200 rpm). The cells were harvested by 
centrifugation (6500 RPM (7,808g)) for 15 min at 4 °C in a yield of 3.7 g/ L of culture 
media. The 11 g cell pellet was suspended in 110 mL of ice-cold lysis buffer (50 mM 
NaH2PO4, 300 mM NaCl, 10 mM imidazole and 1 mM DTT, pH 8.0). The suspension 
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was passed through a French Press at 1200 PSI, and then centrifuged at 4 °C for 60 min 
at 20000 RPM (48,384g). The supernatant was loaded onto a 1.5 × 15 cm Ni-NTA 
column equilibrated with 200 mL lysis buffer and then rinsed with 200 mL lysis buffer. 
The column was washed with 300 mL of wash buffer (50 mM NaH2PO4, 300 mM NaCl, 
50 mM imidazole and 1 mM DTT, pH 8.0), and then eluted with elution buffer (50 mM 
NaH2PO4, 300 mM NaCl, 250 mM imidazole and 1 mM DTT, pH 8.0). The column 
fractions were analyzed by measuring the absorbance at 280 nm and by carrying out 
SDS-PAGE analysis. The desired fractions were combined, concentrated at 4 °C with an 
Amicon concentrator (Amicon) and then dialyzed against Buffer A (50 mM 
triethanolamine, 5 mM MgCl2, 1 mM DTT, pH 7.5). The resulting sample was 
concentrated using a MACROSEP 10K OMEGA and stored at –85 °C. The proteins 
prepared in this manner were shown to be homogeneous by SDS-PAGE analysis. Yield: 
~17 mg protein/g wet cell. 
4.3.5   Recombinant A.  niger DMML molecular size determination 
The theoretical subunit molecular mass of recombinant DMML was calculated by 
using the amino acid composition, derived from the gene sequence, and the EXPASY 
Molecular Biology Server program Compute pI/MW(Appel, Bairoch et al. 1994). The 
subunit size of recombinant DMML was determined by SDS-PAGE analysis using 
molecular weight standards from Invitrogen. The subunit mass was determined by 
electro-spray mass spectrometry (University of New Mexico Mass Spectrometry Lab). 
The native molecular mass was determined by Sephacryl S-200 gel filtration column (1.5 
cm × 180 cm; Pharmacia) chromatography carried out at 4 °C using 0.1 M KCl with 
Buffer B (50 mM K+Hepes and 0.5 mM DTT (pH 7.5)) as the eluant. The column was 
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calibrated using a Pharmacia gel filtration calibration kit (ovalbumin (43 000), aldolase 
(158 000), ribonuclease A (137 000), and chymotrypsingen A (25 000), albumin (67 
000)). 
4.3.6   Enzymatic synthesis of (2R,3S)-dimethylmalic acid by A. niger DMML 
A 300 mL solution of 40 µM enzyme, 5 mM MgCl2, 5 mM DTT, 500 mM 
sodium propionate, 500 mM sodium pyruvate, and 100 mM Tris buffer (pH 7.5) was 
stirred at 25 °C for 3 d. The pH of the solution was adjusted to 10 with 1 M KOH and 
then hydrogen peroxide (30% aqueous, 30 mL) was slowly added. The resulting o ution 
was stirred at 90 °C for 30 min, and then 10 mg of catalase was added. The mixture was 
filtered through a 10 kDa membrane (Amicon), concentrated in vacuo to ca. 100 mL, 
adjusted with 12 M HCl to pH 1, and then extracted with ethyl acetate. The ethyl acetate 
solution was dried over Na2SO4 and concentrated in vacuo to yield a yellow residue, 
which was crystallized from ethyl acetate and petroleum ether, yielding 1.2 g of (2R,3S)-
dimethylmalic acid: mp 108-109 °C  (reported mp 104-106; (Pirzer, Lill et al. 1979); 
[a]25D -13.6 (c = 5, H2O) [reported [a]
25
D -16.4 for c = 5, H2O; (Lill, Pirzer et al. 1980); 
1H-NMR (500 MHz, d-chloroform) d 3.06 (q, J = 7.5 Hz, 1H), 1.44 (s, 3H), 1.36 (d, J = 
7.5 Hz, 3H), 1.25 (s, 1H); 13C NMR d 182.5, 181.2, 74.8, 46.5, 23.6, 10.6; MS (M - 1) 
m/z 161.0442, calcd for C6H9O5 m/z 161.0450. Based on the above data, we can conclude 
that (2R,3S)-dimethylmalic acid was obtained through the aldol reaction of pyruvate and 
propionate catalyzed by DMML. The melting point of (2R,3R)-dimethylmalic acid is 143 
°C (Pirzer, Lill et al. 1979).  
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4.3.7   Activity assays  
Continuous lyase assay. The DMML catalyzed C(2)-C(3) bond cleavages in  (R)-
malate, (S)-malate, (2R)-2-methylmalate, (2S)-2-methylmalate, (2R,3S)-isocitrate, (2R,3S 
& 2S,3R)-2-methylisocitrate (threo isomers), (2R,3S)-isopropylmalate, or 3-butylmalate, 
(2R,3S)-dimethylmalate, and (2R,3S)-2R-ethyl-3-methylmalate were continuously 
monitored spectrophotometrically using a NADH and LDH coupling system. The 
reaction solution (1 mL) contained 5 mM MgCl2, 20 units/mL lactate dehydrogenase, and 
0.2 mM NADH in 50 mM K+HEPES (pH 7.5 and 25 °C). The absorbance of the solution 
was monitored at 340 nm ((∆ε= 6.2 mM-1cm-1). The kinetic constants for catalyzed 
cleavage of (2R)-2-methylmalate, (2R)-2-ethylmalate, (2R,3S)-dimethylmalate, and 
(2R,3S)-2-ethyl-3-methylmalate and (2R,3S & 2S,3R)-2-methylisocitrate were determined 
using assay solutions in which the reactant concentration was varied from 0.5 Km to 10 
Km. In the case of (2R,3S)-2-ethyl-3-methylmalate, reaction solutions contained 600 units 
of lactate dehydrogenase. To check catalyzed cleavage of (R)-malate, (S)-malate, (2S)-
methylmalate, (2R,3S)-isocitrate, (2R,3S)-isopropylmalate, or 3-butylmalate malate, 
kinetic constants were determined with assay solutions in which the reactant 
concentration is 5 mM and the enzyme concentration  is 70 µM. The DMML (150 µM) 
catalyzed conversion of carboxyPEP (10 mM) to phosphinopyruvate was measured in the 
presence of 5 mM Mg2+ using the assay described in (Lu, Feng et al. 2005).  
Fixed-time lyase assay. Reaction solutions initially containing 0.88 µM DMML 
and 1.5-10 mM (2R,3S)-2-propyl-3-methylmalate (or 70 µM DMML and 3-15 mM 
(2R,3S)-2-isobutyl-3-methylmalate), 5 mM MgCl2, and 50 mM K
+HEPES (pH 7.5, 25 
°C) were analyzed at ~20% conversion. A 200-µl aliquot was mixed with 200 µl of 0.2 N 
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HCl and 100 µl of 0.4 M phenylhydrazine hydrochloride. The solution was stirred for 12 
min before the absorbance was measured at either 325 nm (2-propyl-3-methylmalate) or 
326 nm (2-isobutyl-3-methylmalate). The standard curve was constructed for each α-
ketoacid hydrazone by using the same conditions employed in the enzym reaction. The 
molar extinction coefficients for the hydrazones at the wavelength specified above were 
determined to be 6.8 mM-1cm-1 for 2-oxovaleric acid and 6.7 mM-1cm-1 for 4-methyl-2-
oxopentanoic acid. The control reaction lacked DMML. 
OAH assay. OAH activity was assayed according to a published procedure (Lenz, 
Wunderwald et al. 1976). Reaction solutions (0.5 ml) initially contained 0.14-6 mM 
oxaloacetate, 7.0 µM DMML, and 5 mM MgCl2 in 50 mM K
+HEPES (pH 7.5 and 25 
°C). The reaction was monitored at 255 nm for the disappearance of the enol tautomer of 
oxaloacetate (∆ε= 1.1 mM-1cm-1). The rate of oxaloacetate consumption via spontaneous 
decarboxylation was measured prior to initiating the enzymatic reaction to determine the 
“background rate”. The background rate was subtracted from the reaction rate measured 
in the presence of DMML. The influence of the buffer properties on the DMML kinetic 
behavior was tested by replacing the 50 mM K+HEPES (pH 7.5) of the reaction solutions 
with 0.1 M imidazole (pH 7.6). The products formed from reaction of 700 µM DMML 
with 30 mM oxaloacetate in 50 mM potassium phosphate (pH 7.5, 25 °C) containing 5 
mM MgCl2 were examined by 
1H-NMR. Following incubation for 2 h, the enzyme was 
removed using a centricon and D2O was added to a final concentration of 15 % (v/v) 
before the spectrum was measured with methanol serving as an inter al standard (3.39 
ppm). The acetate signal was observed as a singlet at 1.96 ppm.  
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4.3.8   Steady-state kinetic constant determination for A. niger DMML substrates 
The steady-state kinetic parameters (Km and kcat) were determined from the initial 
velocity data measured as a function of substrate concentration. The initial velocity data 
were fitted to Equation 1 with KinetAsystI, 
                                                         V0 = Vmax[S]/(Km+[S])                                              (1) 
where [S] is the substrate concentration, V0 is the initial velocity, Vmax is the maximum 
velocity, and Km is the Michaelis-Menten constant for the substrate. The kcat value was 
calculated from Vmax and the enzyme concentration using the equation kcat=Vmax/[E], 
where [E] is the protein subunit molar concentration in the reaction calculated from the 
ratio of measured protein concentration and the protein molecular mass (31, 986Da). 
4.3.9   Determination of inhibition constants for A. niger DMML inhibitors 
The competitive inhibition constant Ki was determined for 3,3-diflurooxaloacetate 
(0, 10, 20 µM), oxalate (0, 2, 4, 10 mM) and phosphonopyruvate (0, 5, 10, 20 µM) using 
(2R,3S)-2-ethyl-3-methylmalate (1-10 mM) or  (2R,3S)-dimethylmalate (0.1-2.0 mM) as 
substrate. Assay solutions contained 50 mM K+HEPES (pH7.5, 25 °C), 5 mM MgCl2,, 
600 U/mL LDH and 0.2 mM NADH. The absorbance of the reaction solution was 
monitored at 340 nm. The competitive inhibition constant Ki was determined by fitting 
the initial velocity data to Equation 2 with KinetAsystI. 
                                               V0 = Vmax[S]/(Km(1+(1/Ki))+[S])                                        (2) 
4.3.10  Determination of pH-rate profiles for A. niger DMML catalysis 
The pH dependence of DMML catalysis was measured using (2R,3S)-2-ethyl-3-
methylmalate as the substrate (1-8 mM), 5 mM MgCl2 as the cofactor, and 600 units/mL 
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LDH and 0.2 mM NADH as the coupling system. The dual buffer system consisting of 
reaction solutions were buffered at pH 4.5-5.5 with 25 mM acetate and 25 mM MES, pH 
5.5-8.0 with 25 mM K+HEPES and 25 mM MES, pH 8.0-9.0 with 25 mM K+HEPES and 
25 mM TAPS, pH 9.0-9.5 with 25 mM TAPS and 25 mM CAPSO. The initial velocity 
was fitted with equation 1 to obtain kcat and kcat/Km, which in turn were used with 
equation 3 with KinetAsystI to calculate the apparent pKa values of the ionizing groups. 
                                  Log Y=log(c/1 + [H]/K1 + K2/[H])                                                  (3) 
Where Y=kcat or kcat/Km, c is the pH-dependent value of Y, [H] is the hydrogen ion 
concentration, and K1 and K2 are dissociation constants of groups that ionize.   
4.3.11  Determination of kinetic constants for metal ion activation of A. niger 
DMML  
The steady-state kinetic constants for Mg2+ and Mn2+ activation of DMML for 
hydrolytic cleavage of oxaloacetate (3 mM) to oxalate and acetate and for cleavage of 
(2R,3S)-dimethylmalate (4.7 mM) to pyruvate and propionate were measured with 50 
mM K+-HEPES serving as buffer at  pH 7.5 and 25 °C and using assay procedures 
described above. The initial velocities were measured as a function of Mg2+ or Mn2+ 
concentration varied between 0.5-10 fold M2+ Km. 
4.3.12  Crystallization and data collection 
DMML was crystallized by the vapor diffusion method in hanging drops at room 
temperature, and in two different crystal forms. The first crystal form contained the 
enzyme along with Mn2+ cofactor and the inhibitor 3,3-difluorooxalacetate. The protein 
solution contained 10 mg/mL DMML, 10 mM 3,3,-difluorooxalacetate and 5 mM MnCl2. 
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The reservoir solution consisted of 0.2 M potassium thiocyanate, 0.1 M Bis-Tris propane 
(pH 7.5) and 20% polyethylene glycol (PEG) 3350. The hanging drops contained equal 
volumes of protein and reservoir solutions. Crystals were obtained within 4 days. The 
second crystal form was obtained from DMML solution (10 mg/mL) containing 5 mM 
MgCl2. The reservoir contained 14% PEG 6000 and 0.1 M MES (pH 6.5), and the 
hanging drops contained equal volumes of protein and reservoir solutions. The crystals 
appeared within 2-3 days.  
For data collection, the DMML/Mn2+/3,3-difluorooxalacetate crystals, immersed 
in their original mother liquor, were flashed cooled to 100 K in liquid nitrogen. The 
crystals of the DMML/Mg2+ were cryo-protected prior to flash cooling by briefly 
immersing them in mother liquor containing additional 25% glycerol (in place of water). 
Diffraction data for both crystal forms were collected at ~100 K on the home facility 
consisting of Osmic Max-Flux monochromated X-rays generated by a Rigaku Micro ax 
007 rotating anode equipped with a Rigaku AXIS IV++ image plate detector. Data were 
processed with CrystalClear/d*trek ((Pflugrath 1999), Rigaku/MSC, the Woodlands, 









Table 4.1.  Data collection statistics 
  
Sample DMML-Mn2+-difo DMML-Mg 2+ 
Wavelength (Å) 1.54 1.54 
Space group P32 P1 
Cell dimensions a = 160.6 Å 
b= 160.6 Å 
c = 161.4 Å 
α = 90˚ 
β = 90˚ 
γ = 120˚ 
 
a = 79.1 Å 
b= 115.5 Å 
c = 115.8 Å 
α = 119.7˚ 
β = 90.7˚ 
γ = 96.3˚ 
 
Resolution (Å)a 2.68 (2.78-2.68) 2.28 (2.36-2.28) 
No. observations 303872 321372 
No. unique reflections 123774 154242 
Completeness (%)a 94.7 (90.2) 95.9 (93.8) 
Rmerge
a 0.111 (0.381) 0.082 (0.324) 
Mean I/σIa 6.4 (2.0) 5.8 (2.0) 
Redundancya 2.5 (2.3) 2.1 (2.1) 
aRmerge = ∑hkl [(∑j | Ij – < I > | ) / ∑j | Ij | ].  Values in parentheses are for the highest resolution 
shell. 
 
4.3.13  Structure determination and refinement 
The structure of the protein/inhibitor complex was determined by Molecular 
Replacement using the program Phaser (McCoy, Grosse-Kunstleve et al. 2007) as 
implemented in CCP4 (1994). A partially refined structure of carboxyPEPM determined 
in our laboratory (unpublished result) was used as the search model. The search model 
comprised the entire tetramer except for the gating loops, the C-t rminal regions 
spanning the swapped helices and beyond, the bound ligand, and solvent molecules. 
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Phaser identified the position and orientation of the four tetramers in the asymmetric unit. 
The gating loop and the C-terminus of one monomer were built manually using the 
computer graphic program COOT (Emsley and Cowtan 2004), as were a few loop 
regions that required modification. After completing the building of one molecule, the 
remaining molecules in the asymmetric unit were generated by applying the non-
crystallographic symmetry operators. 
Refinement was performed using a maximum likelihood based refineme t 
strategy using the program REFMAC as implemented in CCP4 (1994; Murshudov, Vagin 
et al. 1997), excluding 5% of the data that were randomly selected for free R analysis 
(Brunger 1992). Refinement of the DMML/inhibitor complex was carried out at 2.6Ǻ 
resolution. Refinement cycles were alternated with visual inspection of maximum 
likelihood weighted (2Fo – Fc) and (Fo – Fc) difference Fourier maps and manual 
rebuilding with COOT (where Fo and Fc are the observed and calculated structure 
factors, respectively).  
 
The inhibitor, cofactors and the solvent molecules were added during the later 
stages of refinement. No restraints were imposed on the inhibitor geometry and metal 
coordination distances. The 3,3-difluorooxalacetate was modeled initially as a ketone, but 
there was always strong positive density attached to C(2) in the (Fo – Fc) difference 
Fourier map indicating that the bound compound is actually a hydrated C(2) gem diol 
(the two forms of the compound are depicted in Fig. 4.1B). This positive density 
persisted throughout the refinement cycles. Towards the end of the refin ment, the 
inhibitor model was changed to gem diol, resulting in an adduct that accounted fully for 
the electron density (Fig 4.2). At the final stage of the refinement, a TLS cycle was 
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employed (M.D.Winn 2001) with each of the sixteen molecules treated as an independent 
unit for fitting T, L and the S displacement tensor parameters. 
 
Figure 4.1: (A) The DMML-catalyzed reaction, and (B) the two structural forms of 3,3-




Figure 4.2: The Fo – Fc electron density map in the vicinity of the 3,3-difuorooxalaceatate and 
Mn2+ cofactor. The ligand model and the metal cofactor were omitted from the calculation. The 
map was contoured at 2 σ level. Atomic colors: carbon – green, oxygen – red, nitrogen – blue, 
fluoride – yellow, Mn2+ – magenta 
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The crystal structure of the wild type protein with the Mg2+ cofactor was also 
determined by Molecular Replacement using the program PHASER with the 
DMML/inhibitor structure as the search model (excluding solvent molecules, ligands and 
the gating loop). This crystal contained three tetramers in the asymmetric unit. Further 
model building and refinement were carried out following the same protocol as described 
for the protein/inhibitor complex. The structure statistics are reported in Table 4.2. 
 
Table 4.2. Refinement statistics 
  
Sample DMML- Mn2+-dfoa DMML- Mg 2+ 
Resolution (Å) 50 – 2.68 46.8-2.28 
No. reflections refined 117564 146395 




 a 0.184/0.188/0.256 0.192/0.196/0.261 
No. Protein atoms 35456 25205 
No. Cofactor (Mn2+ /Mg2+) 16 12 
No. Inhibitor 14 N/A 
No. water molecules 704 1162 
RMSD from ideal geometry 
Bonds (Å) 0.023 0.022 
Angles (°) 2.2 2.1 
Mean B value (Å)2 38.5 36.6 
a R  = ∑hkl | |Fo| – |Fc| | / ∑hkl |Fo|, where Fo and Fc are the observed and calculated 
structure factors, respectively. Rwork corresponds to the reflections used in 
refinement, Rfree refers to randomly selected reflections omitted from the 




4.3.14  Structure based sequence alignment 
The structure based sequence alignment was generated with VAST (Gibrat, 
Madej et al. 1996). DMML served as the query structure, incorporating superfamily 
members with published structure and the unpublished structure of carboxyPEPM 
determined recently in our laboratory (unpublished result). The OAH sequence was then 
aligned using CLUSTALW (Pearson and Lipman 1988; Pearson 1990). Finally, a few 
residues in loop regions required manual adjustment based on inspection of the structure.  
4.3.15  Structure analysis 
Superposition of structures was carried out within the program COOT (Emsley 
and Cowtan 2004). The stereo chemical quality of the structures were assessed with the 
program PROCHECK (Laskowski 1993). The program PyMOL (DeLano 2002) was used 
for structure depictions. 
4.4   Results and Discussion 
4.4.1   A.  niger An07g08390 purification and mass determination 
The recombinant A. niger An07g08390 was purified to homogeneity in a yield of 
20 mg/g wet cells by using a column chromatography-based protocol. The theoretical 
mass of An07g08390 is 32,117 Da whereas that determined by mass spectrometry is 
31,986 Da. Thus, the N-terminal Met is removed by posttranslational modification. The 
SDS-PAGE analysis gave an estimated subunit mass of 32 kDa, whereas the native mass 
measured using molecular size gel filtration chromatography is ~110 kDa, consistent with 
the tetrameric structure observed in the crystal structure.  
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4.4.2   Substrate screen of A. niger An07g08390 
The first objective was to identify potential candidates for the p ysiological 
substrate of the A. niger enzyme An07g08390 by using a focused substrate-activity 
screen. The high sequence identity with the A. niger OAH, and the presence of two key 
lyase catalytic residues (viz. the active site gating loop cysteine presumed to function in 
general acid catalysis, and the protonated active site glutamic acid residue presumed to 
function in electrophilic catalysis (Sharma, Sharma et al. 2000; Liu, Lu et al. 2005)), 
which specifically serve the lyase branch of the superfamily directed our attention to α-
hydroxyacid metabolites as potential substrates. We began the substrate screen with the 
substrates of other known lyase branch members, namely ICL, MICL, PDP (the preferred 
PDP substrate is (2R,3S)-2-alkyl-3-methylmalate), and OAH. Isocitrate is not a substrate 
and 2-methylisocitrate is a very poor substrate (Table 4.3). The oxaloacetate is cleaved to 
oxalate and acetate presumably via the enzyme bound C(2)gem diol. Because the ratio of 
ketone to gem diol under the reaction conditions is 13:1 (Lu, Feng et al. 2005), the actual 
kcat/Km value might be as large as  3 x 10
4 M-1 s-1. The (2R,3S)-2-alkyl-3-methylmalates 
(2R,3S)-dimethylmalate (kcat/Km = 9 x 10
4 M-1 s-1) and (2R,3S)-2-ethyl-3-methylmalate 
(kcat/Km = 5 x 10
4 M-1 s-1) are slightly better substrates. (R)-malate, (S)-malate, (2S)-
methylmalate, (3S)-isopropylmalate and 3-butylmalate are not substrates. Likewise, 
AN07G08390 showed no detectable activity associated with the other family members 
including PEPM, phosphonopyruvate hydrolase, and carboxyPEPM. Based on this 
substrate screen, and the structural and in vivo data reported in later sections, we name 
the A. niger enzyme (2R,3S)-dimethylmalate lyase or simply “DMML”. DMML’s 
assigned biochemical reaction is shown in Fig. 4.1A. 
 83
 
Table 4.3. Steady-State Kinetic and Competitive Inhibition Constants Determin d for A. 
niger DMML in 5 mM MgCl2 and 0.1 M imidazole (pH 7.6 and 25 °C) or 5 mM MgCl2 
and 50 mM K+HEPES (pH 7.5 and 25 °C). 
Reactant                                   kcat(s
-1)              Km(mM)             kcat/Km      K i
(f)
 
                                                                                                    (M-1s-1)         
Oxaloacetate(a)                         0.505 ± 0.005   0.234 ± 0.008    2 x 103   ------ 
oxaloacetate (b)                         0.48 ± 0.02       0.22 ± 0.03        2 x 103   ------ 
2R-methylmalate(c)                  2.64 ± 0.09       2.2 ± 0.2            1 x 103   ------ 
2R-ethylmalate (d)                    4.4 ± 0.7           12 ± 3                1 x 102      _----- 
2R, 3S-dimethylmalate(c)        19.2 ± 0.5          0.22 ± 0.02        9 x 104    ------- 
2R-ethyl- 
3S-methylmalate(d)                  63 ± 2                1.17 ± 0.09       5 x 104     -------              
2R-propyl- 
3S-methylmalate(e)                  0.79 ± 0.01        2.7 ± 0.1           3 x 102     ------- 
2R, 3S &  
2S, 3R-2-methylisocitrate(c)    0.13 ± 0.01        12 ± 3               1 x 101     -------     
2R, 3S-isocitrate(c)                  <1 x 10-5                   ------                 ------        >5 mM(h)  
R-malate(c)                              <1 x 10-5                   ------                          ------           >5 mM(h) 
S-malate (c)                              <1 x10-5             ------                          ------            >5 mM(h)   
2S-methylmalate(c)                  <1 x 10-5            ------                 ------        ------- 
3S-isopropylmalate(c)              <1 x 10-5            ------                 ------        ------- 
3-butylmalate(c)                       <1 x 10-5            ------                 ------        ------- 
phosphonopyruvate (f)             <1 x 10-5            ------                          ------           2.4 ± 0.1 µM(h)   
carboxyPEP(g)                         <1 x 10-5            ------                          ------           >5 mM(h) 
3,3-difluoroxaloacetate           <1 x 10-5            ------                         ------           2.5 ± 0.2 µM(h) 
oxalate                                     -----                    ------                 ------       1.6 ± 0.1 mM(h) 
a The kinetic constants were determined using direct optical method and imidazole as 
buffer. b The kinetic constants were determined using direct optical method and 
K+HEPES as buffer. c The kinetic constants were determined using LDH/NADH 
coupling assay and  (20 units/mL LDH) K+HEPES as buffer. d The kinetic constants were 
determined by LDH/NADH coupling assay (600 units/mL LDH) K+HEPES as buffer.e 
The kinetic constants were determined using the fixed-time phenylhydrazine-based assay 
K+HEPES as buffer. fThe mutase activity was monitored using the pyruvate 
kinase/LDH/NADH coupling assay and K+HEPES as buffer and the hyrolase activity was 
monitored using the LDH/NADH coupling assay and K+HEPES as buffer. gThe malate 
dehydrogenase/NADH coupling assay and K+HEPES buffer was used. hThe Ki value was 
determined using (2R,3S)-dimethylmalate or (2R,3S)-2-ethyl-3methylmalate as substrate 
and K+HEPES as buffer . 
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4.4.3   DMML inhibitors 
In order to determine binding specificities (addressed in a later section), and 
identify a suitable active site ligand for DMML structure determination, a select group of 
compounds were screened as competitive inhibitors (Table 4.3). (2R,3S)-isocitrate, (R)-
malate, (S)-malate and carboxy-PEP are not inhibitors (Ki > 5 mM). Phosphonopyruvate 
and 3,3-difluorooxaloacetate are tight binding competitive inhibitors (Ki = 2.4 and 2.5 
µM, respectively) whereas oxalate is a weak binding competitive inhibitor (Ki = 1.6 mM). 
The 3,3-difluorooxaloacetate, whose structure is shown in Fig. 4.1B, was used in co-
crystallization with DMML. 
4.4.4   Buffer, metal ion and pH effects on DMML catalysis 
In order to determine the optimal reaction conditions for DMML catalysis studies 
were carried out to test buffer, metal ion and pH effects. The pH rate profiles measured 
for DMML are shown in Fig. 4.3. The kcat and kcat/Km values were determined at varying 
concentrations of (2R,3S)-2-ethyl-3-methylmalate and 5 mM MgCl2 as a function of the 
reaction solution pH. The plot of log (kcat) vs pH showed that the maximum activity of 
DMML extends from pH 4.5-7.5 and drops at higher pH (apparent pKa = 8.7 ± 0.1). The 
plot of log (kcat/Km) vs. pH is bell-shaped, indicating a loss of activity at both acidic 
(apparent pKa = 6.1 ± 0.3) and basic pH (apparent pKa value of 8.3 ± 0.3). Therefore, all 
kinetic determinations were carried out at pH 7.5 where DMML displays optimal activity. 
DMML catalysis involves proton transfers between several residue. The protonation 
states of these residues are thus interconnected. Consequently, no attempt is made to 












Figure 4.3: The pH-rate profiles for the DMML-catalyzed reaction of (2R)-ethyl-(3S)-methylmalate 
measured in the presence of 5 mM MgCl2 at 25 °C. See Materials and Methods for details. 
 
The pH rate profiles described above were measured using MES, HEPES, TAPS, 
CAPSO and acetate. No buffer effects were observed. Likewise, the kinetic constants for 
DMML catalyzed cleavage of (2R,3S)-dimethylmalate measured using imidazole or 
HEPES (Table 4.3) are equivalent. The kcat and Km for Mg
2+ activation of DMML 
catalyzed cleavage of (2R,3S)-dimethylmalate (4.7 mM) in 50 mM K+HEPES (pH 7.5, 25 
oC) are 10.7 ± 0.4 s-1 and 22 ± 2 µM, respectively. The kcat and Km for Mg
2+activation of 
DMML catalyzed cleavage of oxaloacetate (3 mM) in 50 mM K+HEPES (pH 7.5, 25 oC) 
are 0.39 ± 0.01 s-1 and 21 ± 2 µM, respectively. The kcat and Km for Mn
2+ activation of 
DMML catalyzed cleavage of oxaloacetate (3 mM) in 50 mM K+HEPES (pH 7.5, 25 oC) 
are 0.92 ± 0.01 s-1 and 8.1 ± 0.7 µM, respectively. Mn2+ and Mg2+ were used in the 































4.4.5   Overall structure of A. niger DMML 
Quaternary Structure: The DMML/Mg2+ crystal structure was refined at 2.3 Ǻ 
resolution (Table 4.2). The asymmetric unit contains 12 subunits assembled into 3 
tetramers. The DMML/ Mn2+/3,3-difluorooxalacetate crystal structure was refined at 2.7 
Ǻ resolution (Table 4.2; Fig. 4.4). The asymmetric unit contains sixteen subunits 
assembled into four tetramers. As with the structures of most of the known PEPM/ICL 
superfamily members, the tetramers are comprised of dimer of dimers with each subunit 
adopting the (α/β)8 barrel fold. Two subunits associate to form the dimer by swapping the 
eighth α-helix of the barrel and the two dimers associate to form the biological tetramer 
(Fig. 4.4). 
 
Figure 4.4: The DMML tetramer structure, highlighting each subunit in different color. The gold 
and salmon molecules swap their (α/β)8 barrel 8
th α-helices, as does the pair of blue and green 
molecules. Mn2+ is depicted as magenta sphere and the inhibitor as stick models with the atomic 
coloring scheme: carbon - green, oxygen – red, fluoride-yellow. 
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Active Site Gating Loop: The active sites of most known PEPM/ICL superfamily 
members are desolvated by the C-terminus of the opposing subunit and by a flexible 
active site gating loop. All twelve subunits of the DMML/Mg2+ crystal structure contain a 
Mg2+ bound to the active site.  The active site gating loop, formed by residues 121 - 130, 
is disordered in all but one subunit (molecule L in the coordinates deposited in the PDB). 
In this subunit the loop adopts a well-defined “open” conformation stabilized by inter-
tetramer contacts (the open conformation is shown in Fig. 4.5A together with the loop-
closed conformation of a DMML molecule bound with 3,3-difluorooxalacetate and 
Mn2+). The DMML/Mn2+/3,3-difluorooxalacetate crystal structure reveals an ordered 
“closed” active site gating loop conformation (Fig. 4.5A) for the fourteen subunits, which 
contain active site bound Mn2+ and 3,3-difluorooxalacetate. The loop residues 121-130 of 
the two subunits (J and N in the coordinates deposited in the PDB) that cont in active site 
bound Mn2+ but no 3,3-difluorooxalacetate ligand, are disordered.  
The C-terminal Segment; Six to ten C-terminal residues of the subunits of the 
DMML/Mg 2+ crystal structure are disordered. On the other hand, the C-terminal 
segments of the subunits observed in the DMML/Mn2+/3,3-difluorooxalacetate crystal 
structure are ordered. Two different C-terminal segment conformations are evident in the 
enzyme/inhibitor complex. The conformation observed in all subunits except for I and M 
allows the C-terminal segment to cover a portion of the entrance to the active site of the 
paired subunit. The remaining active site entrance is covered by the gating loop that has 
assumed the closed conformation. The conformation of the C-terminal segment of 
subunits I and M directs the peptide away from the active site of the paired subunit, thus 





Figure 4.5: Stereoscopic views of superposed DMML molecules depicting conformational 
flexibility. (A) The open gating loop (molecule L of the DMML/Mg2+ structure) and the C-terminus 
of the loop-closed state (molecule A of the DMML/Mn2+/3,3-difuorooxalaceatate structure) occupy 
the same space, implying that the transition requires correlated movement. The open gating loop 
is colored red, the closed gating loop is colored blue. The C-terminal region (residues 292-301) of 
molecule A is highlighted in green. The same region is disordered in molecule L, where the last 
two ordered residues are highlighted in magenta. Mn2+ is shown as a orange sphere and Mg2+ is 
shown as a magenta sphere. The metal co-factor shifts 2.3 Ǻ upon inhibitor binding. The 3,3-
difuorooxalaceatate is shown in atomic colors (carbon-green, oxygen-red, fluoride-yellow).  (B) 
Two different C-terminus conformations in the crystal structure of DMML/Mn2+/3,3-
difuorooxalaceatate complex. Molecule M (whose dimeric partner lacks inhibitor in the active-site) 
is superposed on molecule A (from a dimer occupied with inhibitor in both subunits). Mn2+ and 
atomic color are as in 6A. Gating loops are shown in blue. The C-terminal region (residues 292-
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301) is highlighted in red and green in molecules M and A, respectively. The polypeptide traces of 
the two corresponding molecules are highlighted pale red and pale green. 
 
Notably, the respective subunits that pair with I and M are J and N respectively. 
Subunits J and N differ from the other subunits in that their flexibl gating loops 
(residues 121-130) assume the “open” rather than the “closed” conformation. The “open” 
loop conformation prevents the C-terminal segment of the paired subunit from binding at 
the active site entrance. Thus, the active sites of subunits J and N are fully solvent 
exposed whereas the active sites of all of the other subunits are fully closed to solvent. 
To illustrate this unique feature, a subunit having an ordered, open gating loop 
conformation defined in the crystal structure of the DMML/Mg2+ was superimposed with 
a subunit bound with Mn2+ and 3,3-difluorooxalacetate and having an active site gating 
loop in the closed conformation (Fig. 4.5A). The superposition reveals that part of the 
open gating loop occupies the same space occupied by the C-terminus of a molecule in 
the closed conformation. The correlated movement of the gating loop and the C-terminus 
is thus necessary to avoid clashes. Correlated movement of the C-termini and the gating 
loop is also seen in ICL (Sharma, Sharma et al. 2000). MICL exhibits a different mode of 
correlated movement (Liu, Lu et al. 2005). 
4.4.6   DMML active site structure 
As with other α/β barrel enzymes (Branden 1980), the DMML active site is 
located at the C-terminal end of the barrel’s β-strands. In this section we use the 
DMML/Mn 2+/3,3-difluorooxalacetate crystal structure to identify the active site residues 
that interact with the divalent metal ion cofactor and the substrate ligand (Fig. 4.6A).  The 
3,3-difluorooxalacetate ligand is bound to the active site as the C(2) gem-diol. The gem-
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diol, which is formed by hydration of the 3,3-difluorooxalacetate C(2)=O (Fig. 4.1B), is 
the major structural form observed in aqueous solution (Han, Joosten et al. 2007). Thus, 
one C(2)OH (“reacting C(2)OH”) assumes the position of the C(2)OH in the (2R,3S)-
dimethylmalate (Fig. 4.1A) and the position of the Pro-R C(2)OH in the oxaloacetate 
C(2)gem-diol. 
During catalytic turnover of (2R,3S)-dimethylmalate, (2R,3S)-2-ethyl-3-
methylmalate and oxaloacetate C(2) gem-diol, the reacting C(2)hydroxyl group 
undergoes deprotonatation in concert with, or prior to, C(3)-C(2) bond cleavag . The 
other 3,3-difluorooxaloacetate C(2)OH (“binding C(2)OH”) assumes the position of the 
C(2)CH3 in (2R,3S)-dimethylmalate and the Pro-S C(2)OH in the oxaloacetate C(2)gem-
diol. The reacting C(2)OH coordinates to the Mn2+ and engages in hydrogen bond 
formation with the Arg161 guanidinium group, whereas the binding C(2)OH engages in 
hydrogen bond formation with the Tyr44 hydroxyl group. The C(1)OO- uses on  oxygen 
atom to coordinate to the Mn2+ and to form a bifurcated hydrogen bond with the 
backbone amide NHs of Gly47 and Ala48. The other C(1)OO- oxygen atom engages in 
hydrogen bond interaction with the Thr46 hydroxyl group. The C(4)OO- forms hydrogen 
bonds with the Asn214 side chain, the protonated Glu191 side chain, the backbone amide 
NH of Gly125 and the side chain of Arg161. In addition to the two coordination bonds 
formed with the 3,3-difluorooxaloacetate C(1)OO- and reacting C(2)OH, the Mn2+ 
coordinates the Asp87 carboxylate group and three water molecules to form an octahedral 
geometry complex (average metal-ligand distance of 2.1 Ǻ)  The three water ligands 




Figure 4.6: DMML active site. (A). Stereoscopic representation of Mn2+/3,3-difluorooxalacetate 
binding site. Atomic colors are as in Figure 4.4 except that protein carbon atoms are colored grey. 
Key interactions are highlighted with dotted lines as follows: Coordination to Mn2+ is shown in 
magenta, electrostatic interactions with the ligand are shown in green, and protein interactions 
with Mn2+-coordinated water molecules and protein-protein interactions are shown in black. (B.) 
Stereoscopic representation of the active site modeled with 2R, 3S-dimethylmalate in place of the 
3,3-difluorooxalacetate ligand. The cage represents the space vacated by removing the 3,3-
difluorooxalacetate and the metal cofactor. (C.) Stereoscopic representation of the active 
modeled with 2R-ethyl,3S-methylmalate in place of the 3,3-difluorooxalacetate ligand. 
 
In the absence of the bound 3,3-difluorooxaloacetate only the direct coordination 
of Asp87 carboxylate group to the Mn2+ is evident. The metal coordination in the 
DMML/Mg 2+ structure is somewhat different. Here both Asp87 and Asp89 are directly 
coordinated to Mg2+ in all but one molecule in the asymmetric unit (molecule L in the 
structure deposited in the PDB), wherein only Asp89 serves as direct ligand to Mg2+ and 
a water molecule bridges the Asp87 carboxylate group. The average Mg2+-ligand distance 
is 2.3 Ǻ. A complete octahedral coordination is seen only in one molecule (D). The 
displacement of the metal cofactor position upon ligand binding is on average 2.3 Ǻ, 
comparable with the shifts reported previously for MICL (2.7 Ǻ) and ICL (2.4 Ǻ) 
(Sharma, Sharma et al. 2000; Grimm, Evers et al. 2003; Simanshu, Satheshkumar et al. 
2003; Liu, Lu et al. 2005). 
In order to gain insight into the structure of the enzyme-substrate complex, 
(2R,3S)-dimethylmalate was modeled into the DMML active site in place of the 3,3-
difluorooxalacetate ligand. This model (Fig. 4.6B) conserves the interactions observed in 
the DMML/Mn2+/3,3-difluorooxalacetate crystal structure and defines the position  of the 
R-C(2) and S-C(3) methyl groups relative to the surrounding active site residu . 
Interestingly, the region surrounding the S-C(3)H would also appear to accommodate a 
methyl group. This raised the possibility that the (2R,3R)-dimethylmalate might also be a 
substrate. The (2R,3S)-dimethylmalate was synthesized by using the PDP to catalyze the 
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reaction of pyruvate and propionate and then purifying the dimethylmalate product and 
showing that it has the (2R,3S) configuration (Lu, Feng et al. 2005). The same procedure 
was carried out with DMML substituting for the petal death protein with the same result 
(see Materials and Methods for details). Thus, the preferred substrate for both enzymes is 
the known metabolite (2R,3S)-dimethylmalate. (2R,3R)-Dimethylmalate, on the other 
hand, is not a known metabolite. We will return to the (2R,3S)-dimethylmalate model in 
the discussion of the mechanism of substrate recognition and catalysis in the following 
section. 
Residues that interact with the substrate’s α-ketoacid or α-hydroxyacid moiety 
are conserved in the PEPM/ICL superfamily (Fig. 4.7). The active site residue, Lys122, 
involved in loop opening and closure (Liu, Lu et al. 2004) is also conserved in other 
PEPM/ICL superfamily members except for OAD (Narayanan, Niu et al. 2008). Lys122 
interacts with Asp89 and Glu116, and is protected from unfavorable contact with the 
Mn2+ by two of the three Mn2+ water ligands. 
 Residues defining lyase activity within the PEPM/ICL superfamily are conserved 
in DMML (Fig. 4.6A and 4.7): the catalytic cysteine (Cys124 in DMML), the likely 
proton donor to C(3); Glu191 that shares a proton with the C(4)OO-; and Asn214 that 
anchors Glu191 appropriately for its role in electrophilic catalysis. As observed in MICL, 
ICL, and PDP, the Cys124 thiol group interacts with the backbone amide of His126, thus 
forming an Asx turn. This interaction is expected to decrease the pKa of the cysteine and 
aid in proton transfer to the (“aci-carboxylate”) carbanion intermediate that develops 




Figure 4.7: Structure based sequence alignment of PEPM/ICL superfamily members.  Mg2+/Mn2+ 
coordinating residues are shown in red. DMML residues that are coordinated to the inhibitor 
and/or line the active site are shown in blue as are conserved counterparts of other homologs. 
The lyase signature residues are shown in cyan. The two leucine residues that undergo 
correlated conformational change together with Phe241 are shown in pink. C-terminal residues 
that line the active site of a partner molecule are shown in green. Other invariant residues are 
shown in gray. 
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In the previous section we noted correlated movements between the gating loop 
and the C-terminus of DMML. Correlated shifts are also observed locally in response to 
the 3,3-difluorooxaloacetate ligand, affecting close-by residues includi g a residue of the 
partner subunit. The Phe241 side chain adjusts to enhance van der Waals contact with the 
C(3)F, which suggests that the Phe241 ring interacts with the C(3) methyl group of the 
substrate. The ligand induced change in the Phe241 conformation is accompanied by 
changes in the conformations of neighboring residues, Leu244 of the same subunit and 
Leu275 of the adjacent subunit, suggesting coupled motion (Fig. 4.8).  
 
 
Figure 4.8: Coordinated movement upon ligand binding. The residues of the DMML/Mn2+/3,3-
difuorooxalaceatate complex are shown in green. The residues of the DMML/Mg2+ complex are 
shown in blue. Mn2+ and Mg2+ are shown as magenta and orange spheres, respectively. Atomic 
coloring of the inhibitor is as in figure 4.4. The direction of movement of residues upon ligand 








4.4.7   Structural basis for substrate specificity in DMML  
The substrate and inhibitor screens show that DMML targets the R-malate frame,
yet it does not catalyze the cleavage of R-malate (Table 4.3) nor, remarkably, does it bind 
R-malate (Ki >20 mM). What are the structural determinants that require substitutions at 
C(2) and C(3)?  
Recognition of the C(2) substituent: Based on earlier structure determinations of 
ICL, MICL, and PDP (a (2R,3S)-2-alkyl-3-methylmalate lyase which also possesses 
comparable OAH activity) it has been suggested that a triad of active residues forms a 
pocket that defines the binding site for 2R-C(2) substituent. In MICL, the triad is Phe186, 
Leu234, and Pro236; in ICL the analogous residues are Trp283, Phe345, and Thr347; and 
in the PDP the residues are Phe207, Ala255 and Ser257 (Grimm, Evers et al. 2003; Liu, 
Lu et al. 2005; Teplyakov, Liu et al. 2005). MICL can accommodate a methyl group in 
the pocket, ICL can only accommodate a hydrogen atom, and PDP accommodates 
hydroxyl, methyl, ethyl, or even a propyl group at the 2R-C(2) position (Lu, Feng et al. 
2005). The polar interaction between PDP Ser257 and the pro-S hydroxyl group of the 
oxaloacetate gem-diol is suggested by structural (Teplyakov, Liu et al. 2005) and 
mutagenesis (Joosten, Han et al. 2008) data to account for PDP’s ability to function 
equally well as a (2R,3S)-2-alkyl-3-methylmalate lyase and an OAH. For DMML, the 
“specificity triad” consists of Phe189, Ile238, and Pro240, and thus matches hat of the 
MICL (Fig. 4.6 & 4.7), and similarly, delineating a pocket for a 2R-C(2) methyl group. A 
model of the DMML active site bound with (2R,3S)-2-ethyl-3-methylmalate (Fig. 4.6C) 
indicates that the C(2) ethyl group can be accommodated as well, consistent with the 
observation that (2R,3S)-2-ethyl-3-methylmalate is a good substrate of DMML (kcat/Km = 
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5 x 104 M-1s-1 vs. 9 x 104 M-1s-1 for (2R,3S)-dimethylmalate; Table 4.3). The larger 2R-
propyl group on the other hand is not accommodated well as evidenced by the 300-fold 
drop in the kcat/Km value measured for (2R,3S)-2-propyl-3-methylmalate (Table 4.3). The 
ability of DMML to catalyze hydrolytic oxaloacetate cleavage (Table 4.3) can perhaps be 
explained by the polar interaction between the Tyr44 and the pro-S hydroxyl group of the 
oxaloacetate gem-diol as is suggested by the structure of the DMML/Mn 2+/3,3-
difluorooxaloacetate (Fig. 4.6A). Tyr44 does not correspond spatially to the Ser257 of the 
PDP, but rather its sequence counter part in PDP is Phe64. Replacement of the DMML 
Tyr44 with Phe by site-directed mutagenesis removed all detectabl  activity towards 
(2R)-2-methylmalate, (2R,3S)-dimethylmalate, (2R,3S)-2-ethyl-3-methylmalate and 
oxaloacetate (Table 4.4). For MICL, we proposed that the Tyr43 (counterpart of OAH 
Tyr44) hydroxyl group (which is hydrogen bonded to His113, also conserved in OAH) 
may form part of the catalytic machinery (Liu, Lu et al. 2005). The elimination of all 
catalytic activities in the DMML Y44F mutant supports this proposal as does the 
conservation of the Tyr in most of the lyases within the PEPM/ICL superfamily. The 
catalytic activity of PDP, which contains a Phe-Phe pair instead of the Tyr-His pair might 
be rationalized by the presence of an internal water molecule that plays a similar role to 
the hydroxyl group of the Tyr residue in all other lyases. The PDP he and its His 
counterpart in DMML and MICL are oriented differently such that the PDP contains a 






Table 4.4. Steady-State kinetic constants determined for the A. niger DMML site-
directed mutant mutants for the catalyzed conversion of (2R,3S)-dimethylmalate 
(DMM) to pyruvate and propionate, or the catalyzed conversion of oxaloacetate (OA) 
to acetate and oxalate, 50 mM K+HEPES buffer (pH 7.5 and 25˚ C) containing 5 mM 
MgCl2. 
 
DMML       substrate                  kcat (s
-1)                       Km (µM)             kcat/Km (M
-1s-1) 
WT              DMM                   19.2 ± 0.5                         220 ± 20                9 × 104 
Y44Fa           DMM                  < 1 x 10-5                             -------                      ---- 
D59A           DMM                 (4.27 ± 0.09) ×10-4           7400 ± 400             6 × 10-2  
D59S            DMM                  (1.4 ± 0.1) ×10-4              6000 ± 1000           2 × 10-2  
C124A          DMM                  (1.78 ± 0.05) ×10-4          36 ± 3                     5 × 100  
C124S          DMM                   (1.21 ± 0.05) × 10-4         3600 ± 300             3 × 10-2 
P240Sb          DMM                  11.7 ± 0.6                        5900 ± 700              2 × 103             
P240T           DMM                   2.8 ± 0.2                         4100 ± 800              7 × 102 
WT                 OA                     (4.8 ± 0.2) × 10-1             220 ± 30                  2 × 103  
Y44F              OA                       < 1 x 10-5                                  --------                      ------- 
C124A            OA                      (1.25 ± 0.01)×10-1          142 ± 3                   9 × 102 
C124S            OA                      (8.1 ± 0.2) ×10-2              27 ± 3                     3 × 103 
P240Sb            OA                       (3.57 ± 0.08)×10-1         1110 ± 70                3 × 102 
P240T            OA                       (8.2 ± 0.2) ×10-2             1220 ± 3                  7 × 101 
aThe same lack of catalytic activity was observed with 2R-methylmalate nd 2R-ethyl-
3S-methylmalate serving as substrate.   
bOwing to insolubility of  “native” recombinant DMML P240S, the His6-tagged  
protein was prepared instead. It proved to be robust. The wild-type DMML was also 
prepared as the His6-tagged protein and shown to possess the same level of catalytic 
activity as the wild-type DMML lacking the His6-tag. 
 
The counterpart to the PDP Ser257 in the Botrytis cinerea OAH is Ser260. The B. 
cinerea OAH activity (kcat/Km = 2 x 10
5 M-1 s-1) (Han, Joosten et al. 2007) is 10-fold 
greater than that of PDP (kcat/Km =  2 x 10
4 M-1 s-1) (Lu, Feng et al. 2005) and 100-fold 
greater than that of DMML (kcat/Km = 2 x 10
3 M-1 s-1; Table 4.4). This higher OAH 
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activity has however been gained at the expense of the (2R,3S)-2-alkyl-3- methylmalate 
lyase activity, which is three orders of magnitude lower (kcat/Km = 2 x 10
2 M-1 s-1) (Han, 
Joosten et al. 2007). In contrast, PDP (kcat/Km = 2 x 10
4 M-1 s-1 for (2R,3S)-2-ethyl-3-
methylmalate) (Lu, Feng et al. 2005) and DMML (kcat/Km = 9 x 10
4 M-1 s-1 for (2R,3S)-
dimethylmalate) (Table 4.3) have retained the (2R,3S)-2-alkyl-3-methylmalate lyase 
activity. The substitution of the PDP Ser257 with Pro reduces its OAH activity 10-fold 
and the (2R,3S)-2-ethyl-3-methylmalate lyase activity 2-fold (Joosten, Han et al. 2008). 
The substitution of the B. cinerea OAH Ser260 with Pro reduces its OAH activity 40-fold 
and increases the (2R,3S)-dimethylmalate lyase activity 15-fold (Joosten, Han et al. 
2008). In the present study, the DMML P240S and P240T mutants were prepared and 
tested for DMML and OAH activities. Both activities drop in the wo mutants, however 
the DMML activity is more greatly reduced (45 and 130-fold, respectively) than is the 
OAH activity (6 and 60-fold, respectively) (Table 4.4).  
Together, these results suggest that the functional boundary between OAH and 
(2R,3S)-2-alkyl-3-methylmalate lyase activities among the fungal OAH and DMML and 
the plant PDP is not set solely by a single residue. Whereas th  presence of OAH activity 
in the fungal OAH and plant PDP correlates with the presence of the Ser260 and Ser257, 
respectively, the fungal DMML also has substantial OAH activity despite the Pro at this 
position. Perhaps the Tyr44 in DMML compensates for the absence of a Ser at position 
240, and indeed the fact that OAH also has a Tyr at this position may explain why its 
activity towards oxaloacetate is reduced only 40-fold in the S260P mutant. However, the 
OAH activity is only 10-fold lower in the PDP S257P mutant than in the wild-type 
enzyme yet the Tyr44 counterpart in PDP is Phe (as stated above,  water molecule may 
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substitute for the Tyr hydroxyl group). On the other hand, the presence of Pro (natural in 
the DMML and introduced by site directed mutagenesis in the OAH and PDP) rather than 
Ser at C(2)-substitutent binding pocket clearly enhances (2R,3S)-2-alkyl-3-methylmalate 
lyase activity.  
Recognition of the C(3) substituent: The C(3) 3S-methyl group is important for 
the catalytic efficiency of DMML as is evidenced by the reduced kcat/Km (~72 fold) of 
2R-methylmalate compared with (2R,3S)-dimethylmalate (and ~145-fold for 2R-
ethylmalate compared with (2R,3S)-2-ethyl-3-methylmalate). The residues that delineate 
the C(3) methyl binding pocket are hydrophobic, including Ala48, Val216, Phe241, 
Pro240, and the partner subunit residues Pro272 and Phe276 (highlighted in green i Fig. 
4.7). The C(3) methyl group appears to contribute to both binding affinity a d orientation 
of the substrate with respect to the catalytic machinery. The abs nce of this methyl group 
is expected to diminish both types of contributions. Isocitrate is not a substrate of 
DMML, and 2-methylisocitrate is a very poor substrate, consistent with the electrostatic 
conflict that would be created by accommodating a C(3)CH2COO- group in the 
hydrophobic pocket in place of the methyl group. Isocitrate and 2-methylisocitrate are 
also poor substrates for PDP owing to the clash between the C(3)CH2COO- group and the 
hydrophobic side chains of Ile233, Leu258 and the benzyl ring of Tyr68 (Lu, Feng et al. 
2005; Teplyakov, Liu et al. 2005). 
4.4.8   Catalytic mechanism  
Previously, we (Liu, Lu et al. 2005) and others (Britton, Langridge et al. 2000; 
Sharma, Sharma et al. 2000; Britton, Abeysinghe et al. 2001; Grimm, Evers et al. 2003) 
have proposed a catalytic mechanism for the lyase branch of the PEPM/ICL superfamily 
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that consists of deprotonation of the substrate C(2)OH group followed by protonation of 
the carbanion that develops on  the C(3) as the C(2)-C(3) bond is cleaved (Liu, Lu et al. 
2005). A proposed mechanism for DMML catalysis is shown in figure 4.9. The identity 
of the general base in ICL and MICL has not been demonstrated. We considered several 
possibilities: one of two Mg2+-coordinated water molecules, each of which hydrogen 
bonded to a conserved carboxylic group (Asp59 and Glu116 in DMML); the invariant 
arginine (Arg161 in DMML); the Tyr-His pair discussed above (Tyr44 and His114 in 
DMML) (Liu, Lu et al. 2005). The present structure of 3,3-difluorooxaloacetate bound 
DMML (Fig. 4.6A) and the derived DMML/(2R,3S)-dimethylmalate model (Fig. 4.6B) 
exhibit the same groups as candidates for the role of general base. Because the Νξ1 and 
Νξ2 groups of Arg161 interact with both the C(3)COO- and the C(2)OH substrate groups, 
it is conceivable (although unusual) that a proton is transferred from the C(2)OH to the 
one nitrogen atom concomitantly with a proton that is transferred from the other nitrogen 
to the C(3)COO-. Alternatively, the Mg2+ water ligand bound to Asp59 and Lys122 is an 
attractive candidate for general base catalysis. Unfortunately, the site directed 
mutagenesis results do not allow us to assign the DMML general base. In addition to the 
replacement of Tyr44 by Phe that eliminated catalytic activity, we also replaced Asp59 
with Ala and with Ser by site directed mutagenesis. The kcat/Km value for (2R,3S)-
dimethylmalate cleavage is reduced 6-orders of magnitude in both mutants (Table 4.4). 
Similarly impaired activity was observed with Asp mutants in MICL and PDP (Grimek, 






Figure 4.9: Proposed catalytic mechanism of DMML.  
 
The candidates for general acid are the Cys124/Glu191 pair in DMML and their 
counter parts in ICL, MICL, and PDP. The Cys124 thiol group (assisted by the backbone 
amide NH of Gly125) is correctly orientated to protonate the C(3) upon C(2)-C(3) 
cleavage, whereas the Glu191 is correctly orientated to share a proton to the C(3)COO- 
(and is also engaged in hydrogen bond interaction with the side chains of Arg161 and 
Asn212 and the backbone amide NH of Cys124) (Fig. 4.6A). In the present study, the 
contribution that Cys124 makes to catalysis of (2R,3S)-dimethylmalate and oxaloacetate 
cleavage was probed by site directed mutagenesis. Because Cys124 does not bind either 
substrate the kinetic constant of interest is kcat. The kcat for oxaloacetate cleavage drops 
from 0.5 s-1 for the wild-type DMML to 0.1 s-1 for the C124A mutant and 0.08 for the 
C124S mutant (viz. ~5 fold) (Table 4.4).  In contrast, the kcat for (2R,3S)-dimethylmalate 
cleavage drops from 19 s-1 for the wild-type DMML to 2 x 10-4 s-1 for the C124A mutant 
and 1 x 10-4 s-1 for the C124S mutant (viz. 5 orders of magnitude) (Table 4.4). Why is 
Cys124 not required for oxaloacetate cleavage? One possible answer is that the pro-S 
C(2)OH (the binding OH) of the hydrated oxaloacetate acts as a surrogate proton donor. 
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Another intriguing question is why 3,3-difluorooxalacetate, an analogue of the 
oxaloacetate gem diol intermediate/transition state is not cleaved by DMML. From the 
outset, it would appear that the two fluoride atoms should stabilize the carbanion by 
delocalizing the negative charge and therefore the compound should be susceptible to 
cleavage. On the other hand, the prevalence of the C(2) gem diol form in solution 
suggests it as a more stable form than the ketone form of 3,3-difluorooxalacetate. This is 
reminiscent of fluorinated ketones and α-keto acid inhibitors of serine proteases. The 
electron withdrawing fluoride is thought to stabilize the diol form over the ketone, and 
these inhibitors add to the enzyme’s catalytic serine residue to form a stable tetrahedral 
transition state analog (Imperiali and Abeles 1986; Stein, Strimpler et al. 1987; Brady, 
Wei et al. 1990). 
4.4.9   DMML biological function  
 OAH homologs are ubiquitous in filamentous fungi. The genome of the 
acidogenic A. niger encodes four OAH family members. Genetic and biochemical 
evidence confirmed that An10g00820 encodes the protein responsible for oxalic acid 
formation (Han, Joosten et al. 2007). Another A. niger OAH paralog encoded by 
An07g08390 was identified by our studies as DMML. Current and previous analyses 
(Joosten, Han et al. 2008) indicate that locally conserved syntenic orthologs of DMML 
that share over 80% sequence identity are present in all Aspergillus species sequenced to 
date. Putative orthologs were also detected in more distantly related fungi. 
In Eubacterium barkeri DMML is a key enzyme in nicotinate catabolism, 
catalyzing the last of nine enzymatic steps (Alhapel, Darley et al. 2006). The E. barkeri 
DMML shares 40% amino acid sequence identity with the A. niger DMML (recall the 
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57% sequence identity between the A. niger DMML and OAH). BLAST analysis 
(Altschul, Madden et al. 1997) of the A. niger genome for the presence of a similar 
pathway revealed the presence of some genes with sequence homology to E. barkeri 
nicotinate pathway enzymes. For instance, the small and large subunit of the E. barkeri 
2,3-dimethylmalate dehydratase show 36% and 32% sequence identity with the two 
domains of homo aconitase, an enzyme involved in fungus-specific lysine biosynthesis 
encoded by An15g00350. Another example is the presence of a 3-methylitacona e 
isomerase homolog (39% identity). However, no homologs were identified for 2-
methyleneglutarate mutase, 6-hydroxynicotinate reductase, 2-(hydroxymethyl)glutarate 
dehydratase, and enamidase. Thus from the genome sequence it is not evident that a 
nicotinate catabolic pathway similar to E. barkeri exist in A. niger. Moreover, the 
presence of the nicotinate pathway in Aspergillus has not been reported. Growth 
experiments revealed that when nicotinamide was used as a sole carbon source, A. niger 
remained viable but the growth was exceedingly poor. 
An in house library of 140 A. niger Affymetrix DNA arrays (GEO: acc no 
GPL6758) was screened for conditions that support DMML expression. DMML was 
expressed when sorbitol was used as a sole carbon source and was repres ed in the 
presence of fructose. CREA is a major regulatory protein that mediates carbon catabolite 
repression. In strain NW283 (a creA d4 mutant strain relieved of carbon repression), the 
expression of DMML was derepressed. Taken together, the transcriptome analysis 
showed that unlike the OAH encoding gene (An10g00820), the DMML encoding gene 
(An07g08390) is under carbon catabolite repression. This accounts for why DMML does 
not compensate for OAH in the A. niger OAH gene knockout mutant, which does not 
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form oxalic acid. Therefore, the genetic and genomic data suggest that DMML plays a 
role in an evolutionarily conserved fungal pathway but presently this pathway is 
unknown.  
4.5   Conclusions 
For the A. niger mutant lacking the gene encoding OAH, the organism does not 
produce oxalate, yet its genome contains four more genes that exhibit sequence 
homology with the confirmed OAH, including one that shares 57% sequence identity 
with OAH. We show here that the latter gene encodes the enzyme 2,3-dimethylmalate 
lyase (DMML), and that this enzyme also catalyzes the hydrolsis of oxaloacetate albeit 
with 40-fold lower efficiency than it catalyzes the primary reaction. The OAH catalytic 
efficiency of DMML is 100-fold lower than the catalytic efficiency of an authentic OAH 
(Han, Joosten et al. 2007). The sequence-based phylogeny tree of the PEPM/ICL 
superfamily was constructed previously (Liu, Lu et al. 2005). Both DMML and OAH 
belong to a clade that also includes PDP and carboxyPEPM. Hence this is a clade of 
proteins of high sequence identities, typically 40% and above, that clusters together 
enzymes that share common catalytic machinery but perform multiple activities and 
exhibit broad substrate profiles. The 3D structures of representative members of the 
clade, PDP (Teplyakov, Liu et al. 2005),  DMML (this work), OAH (unpublished results) 
and carboxyPEPM (unpublished results), are very similar, as is the conservation of the 
residues that define lyase activity. In contrast to this clade that contains multi-functional 
enzymes, two other clades encompassing primary metabolism enzymes, one defining 
MICL activity and the second ICL activity, contain highly specialized sequence families 
with specificity towards a single substrate. At the structural level, it appears that the 
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highly specialized enzymes evolved an optimized active site architecture that binds only 
one substrate productively, whereas the promiscuous enzymes contain fea ures allowing 
accommodation of several substrates in a catalytically productive mode. 
Accession numbers 
The coordinates and structure factors have been deposited in the Protein Da a 




Chapter 5   Conclusion 
The PEPM/ICL superfamily was chosen for study because of the in eresting and 
diverse chemical reactions they perform (C-P and C-C bond formati n nd cleavage) 
even though they share similar overall fold and active site architecture, and exhibit high 
level of sequence identity. The biological and biochemical functions of some of these 
enzymes are already known, for others, the available structure/sequ nce information 
indicates that they might be incorrectly annotated in sequence databases and/or that they 
perform novel functions. The information gained from the structural studies was used to 
relate active site structure to catalysis and to identify markers, which were applied in the 
assignment of function to other family members. This work provides insights into the 
evolution of function from ancestral active site templates. Previously, the collaboration 
with Prof. Dunaway- Mariano’s laboratory led to correction of the functio al annotation 
of the petal death protein from CPEPM to a broad specificity lyase acting on (2R)-
ethyl,(3S)-methylmalate, and oxaloacetate (Teplyakov, Liu et al. 2005). My own work 
led to the discovery of  a novel biochemical reaction performed by P. aeruginosa 
PA4872, the decarboxylation of oxaloacetate and 3-methyl oxaloacetate (Narayanan, Niu 
et al. 2008) and to the discovery of the presence of (2R), 3S)-dimethylmalate lyase in the 
A. niger genome. 
5.1 Structural insights  
 
 My studies of OAD and DMML confirmed that the common structural fe tures of 
the PEPM/ICL superfamily, pertaining to the oligomerization state, overall fold, helix 
swapping, the presence of a capping loop, location of the active site, and the requirement 
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of a divalent metal ion holds true in these two new superfamily embers. Yet, there were 
interesting features unique to each of these enzymes.  
 In OAD a novel mode of helix swapping occurs in which the C-terminus ensuing 
the swapped helix reverses direction compared with other structures (Fig. 3.2B). This 
alternative trace led to the formation of a channel extending from the active site to the 
solvent (Fig 3.5A), which may be utilized during catalysis in a manner that requires 
further investigation. DMML exhibits the common overall structural scaffold 
characteristic of the PEPM/ICL superfamily. In addition, DMML structures show that 
opening and closing of the active site capping loop of one molecule is coupled to the 
movement of the C-terminus of the partner molecule (Fig 4.5). Analogous m vement has 
been observed in ICL (Sharma, Sharma et al. 2000) but not in PEPM. MICL exhibits a 
unique movement of its C-terminus.  
5.2 Function  fingerprints 
 
 In the PEPM/ICL superfamily, residues lining the active sit perform a particular 
function: catalytic or substrate and metal cofactor binding. All members have the 
conserved Mg2+ coordinating residues. Presence of the conserved substrate coordinating 
residues such as the arginine and the N-terminus of a short helix enables the stabilization 
of the oxyanion intermediate. Presence of the lyase signature residues (Cys, Glu and Asn) 
infers the stabilization of an aci-carboxylate intermediate involved in the catalysis of all 
lyases, and OAH (along with a tetrahedral oxyanion intermediate). Among lyases the 
different enzymes are distinguished by the size and nature of residues surrounding the 
active site that define pockets for binding substrate groups. For example, the residues 
constituting the specificity triad dictates the nature of the C(2) substrate substituent. 
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Between the two highly specialized lyases of this superfamily (ICL and MICL), the 
presence of Ser315, Ser317, and Thr347 provides the fingerprint for distinguishin ICL 
from MICL, whereas the Arg241, Arg270, and Thr212 are the signature residues of 
MICL (Liu, Lu et al. 2005). Those enzymes that do not possess the abov  mentioned aci-
carboxylate stabilizing residues stabilize an enolate oxyanion intermediate. Among these 
enzymes, a threonine or an asparagine at the position corresponding to the catalytic 
cysteine of the lyases on the gating loop suggests phosphonopyruvate hydrolase and 
phosphoenolpyruvate mutase, respectively. Among the PEPM/ICL superfamily members, 
CPEPM is an unusual candidate showing a lyase signature sequence yet p rforming a 
mutase activity via a pyruvyl enolate intermediate. More studies are required to 
understand the mechanism of this enzyme.  
From the studies on DMML, we noticed that the counterpart of Pro240 in the 
OAH and PDP sequences is a serine. The results from our mutant stdies (summarized in 
table 5.1), involving the P240S and P240T mutants of DMML, the S257P mutant of PDP 
and the S260P mutant of OAH (Joosten, Han et al. 2008) show that the presence of a 
proline enhances 2R-alkyl, 3S methylmalate lyase activity in OAH but not in PDP. On 
the other hand, the P240S mutant of DMML failed to show significant improvement of 
OAH activity. Thus, presence of a serine residue is not an obvious signature of OAH 
activity. In all these mutants, it is the Km value that is affected the most indicating that 
Pro in DMML and Ser in OAH and PDP play an important role in substrate binding 
rather than catalysis. Moreover, the failure of these mutants to improve or impair specific 
functions underscores the complexity of evolutionary processes where function change is 
followed by further mutations that lead to subtle structural adjustments that optimize the 
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new function. Consequently, reversal of function cannot be engineered by a single 
mutation. 
Table 5.1: Comparision of catalytic efficiency of the mutant and wild type proteins of DMML, OAH 
and PDP. 
 
 Substrate kcat (s
-1) Km  (µM) kcat/Km (M-1s-1) 
DMML - WT 
 
DMM 19.2 + 0.5 220 + 20 9 x 10
4 
DMML - P240S 
 
DMM 11.7 + 0.6 5900 + 700 2 x 103 
OAH - WT 
 
DMM 0.0293 + 0.0007 140 + 10 2 x 102 
OAH - S260P 
 
DMM 0.074 + 0.002 22 + 2 3 x 103 
PDP - WT 
 
DMM 8.4 + 0.4 530 + 30 2 x 104 
PDP - S257P DMM 8.3 +0.2 660 + 40 1 x 104 
DMML - WT 
 
OA (4.8 + 0.2) x 10-1 220 + 30 2 x 10
3 
DMML - P240S 
 
OA (3.57 + 0.08) x 10-1 1110 + 70 3 x 102 
OAH - WT 
 
OA 17.4 + 0.2 65 + 3 2 x 105 
OAH - S260P 
 
OA 0.98 + 0.03 220 + 20 5 x 103 
PDP - WT 
 
OA 2.72 + 0.06 130 + 10 2 x 104 
PDP - S257P OA 4.1 +0.1 840 + 50 5 x 103 
 
 Our studies of OAD revealed that at both the sequence and structure levels there 
are two residues unique to the OAD clade, yet the mutagenesis failed to confirm these 
residues as marker of OAD activity. The possibility that the capping loop may not 
undergo closure cannot be ignored because the loop lacks the conserved Lys r sidue. The 
presence of the channel leading to the active site is also not understood. The lack of loop 
Lys and its relatively hydrophobic nature may serve as the signature sequence of 
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decarboxylase activity but this awaits the structure determination of an enzyme/substrate 
complex. 
5.3 Evolutionary perspective 
 
 In the phylogeny tree of the PEPM/ICL superfamily (Fig 1.5) the ICL and MICL 
enzymes are each clustered together. These two lyases have evol d to be highly 
specialized (Liu, Lu et al. 2005). Interestingly, within the highly specialized cluster of 
ICL, there is a second class of proteins called the ICL2’s that possess MICL activity, 
suggesting a different route of evolution of some MICL’s, closer to the authentic ICLs. 
The structurally divergent transferases are well separated from the rest of the 
clusters. In this group, many characteristic features of the PEPM/ICL superfamily such as 
the presence of a capping loop, tetramer formation and metal coordination pattern differ. 
The grouping of the enzymes acting on a P-C bond, PEPM and PPHA, in the same cluster 
of the phylogeny tree underscores the possible evolution of these proteins from common 
ancestral active site architecture. 
A cluster adjacent to the MICL cluster in the phylogeny tree consists of various 
enzymes that show diverse functional specialization despite their high sequence identity. 
This is an intriguing cluster that exhibits overlap of functions betwe n its members, as 
exemplified by the fact that PDP, OAH and DMML all perform both OAH and lyase 
activities but with varied catalytic efficacies. The sequence diff rences in the active sites 
of these enzymes are small, hence the catalytic machinery of the lyases and OAH are 
related. The main difference is in the absolute requirement for the catalytic Cys for lyase 
activity whereas OAH activity can proceed without the Cys, albeit at lower efficacy.  In 
general, these enzymes have broad substrate specificity unlike the specialized ICL and 
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MICL CarboxyPEPM remains an enigma because its mutase activity is extremely low in 
addition to its clustering with the lyases and OAH. My studies on a protein from this 
cluster revealed that the extremely close relative of OAH (~60% identity) is actually a 
DMML. Based on the present information this clade appears to be at a crossroad of 
function diversification and it may include additional enzymes with novel functions. 
 The phylogeny tree showed two distinct branches comprising proteins of 
unknown functions. From one of those branches we found the novel enzyme OAD from 
P. aeruginosa whose crystal structure was crucial to function assignment. The function of 
the second family remains unknown. Some of the sequences are annotated as “PEPM and 
related enzymes”, some as “probable CPEPM”, and others as hypothetical proteins. 
Recently, the structure of a family member was published containi g an intrinsic α-
ketoglutarate, but this structure does not provide clues about the function of he enzyme 
and its family relatives. The phylogeny analysis indicates that the functional diversity of 
the superfamily may be broader than is currently known, which means th t there are 
numerous enzymes that catalyze novel C-C or P-C bond forming/cleaving reactions left 
to be discovered and analyzed.  
5.4 Future directions 
 
 Additional X-ray structures of the PEPM/ICL superfamily memb rs are needed to 
provide the basis for understanding the mechanisms of action at the tomic level and for 
understanding function diversification. We still do not understand the catalytic 
mechanism of OAD and expect that a structure of the enzyme/substrate complex will be 
informative. The biological role of the enzymes also needs further inv stigations. Within 
the DMML and PDP clade, the structures of OAH and CPEPM are yet to be determined, 
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which will hopefully clarify the underlying determinants of broad substrate specificity. 
There may be additional functions within this clade because A. niger contains four OAH 
paralogs (one of which is DMML). Finally, structure/function studies are required to 
discover the function of the remaining clade of “hypothetical proteins”. Once these goals 
are achieved, many more sequenced proteins will be annotated reliably. 
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